<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Laboratory Values Clinical Reference - 100 Tests</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; background: linear-gradient(135deg, #1a1a2e 0%, #16213e 100%); min-height: 100vh; padding: 20px; color: #e0e0e0; }
        .header { text-align: center; padding: 30px 20px; background: rgba(255,255,255,0.05); border-radius: 16px; margin-bottom: 20px; border: 1px solid rgba(255,255,255,0.1); }
        .header h1 { font-size: 28px; color: #fff; margin-bottom: 8px; }
        .header p { color: #aaa; font-size: 14px; }
        .controls { background: rgba(255,255,255,0.05); border-radius: 16px; padding: 20px; margin-bottom: 20px; border: 1px solid rgba(255,255,255,0.1); }
        .search-box { width: 100%; padding: 14px 20px; border: 2px solid rgba(255,255,255,0.2); border-radius: 12px; font-size: 16px; background: rgba(0,0,0,0.3); color: #fff; margin-bottom: 15px; }
        .search-box::placeholder { color: #888; }
        .filter-section { margin-bottom: 15px; }
        .filter-label { font-size: 12px; color: #888; margin-bottom: 8px; text-transform: uppercase; letter-spacing: 1px; }
        .filter-buttons { display: flex; flex-wrap: wrap; gap: 8px; }
        .filter-btn { padding: 8px 16px; border: 1px solid rgba(255,255,255,0.2); border-radius: 20px; background: transparent; color: #ccc; cursor: pointer; font-size: 13px; transition: all 0.2s; }
        .filter-btn:hover { background: rgba(255,255,255,0.1); }
        .filter-btn.active { background: #4a90d9; border-color: #4a90d9; color: #fff; }
        .toc-section { background: rgba(255,255,255,0.05); border-radius: 16px; padding: 20px; margin-bottom: 20px; border: 1px solid rgba(255,255,255,0.1); }
        .toc-toggle { width: 100%; padding: 15px; background: rgba(76, 175, 80, 0.2); border: 1px solid rgba(76, 175, 80, 0.4); border-radius: 12px; color: #81c784; font-size: 16px; cursor: pointer; display: flex; justify-content: space-between; align-items: center; }
        .toc-content { display: none; margin-top: 15px; }
        .toc-content.show { display: block; }
        .toc-grid { display: grid; grid-template-columns: repeat(auto-fill, minmax(200px, 1fr)); gap: 15px; }
        .toc-category h4 { color: #4a90d9; margin-bottom: 10px; font-size: 14px; }
        .toc-list { list-style: none; }
        .toc-list li { margin-bottom: 5px; }
        .toc-link { color: #aaa; text-decoration: none; font-size: 13px; }
        .toc-link:hover { color: #fff; }
        .results-info { color: #888; font-size: 14px; margin-bottom: 15px; padding-left: 5px; }
        .lab-grid { display: grid; gap: 20px; }
        .lab-card { background: rgba(255,255,255,0.05); border-radius: 16px; padding: 25px; border: 1px solid rgba(255,255,255,0.1); }
        .lab-header { display: flex; justify-content: space-between; align-items: flex-start; margin-bottom: 15px; flex-wrap: wrap; gap: 10px; }
        .lab-title { font-size: 20px; font-weight: 600; color: #fff; }
        .lab-subtitle { font-size: 14px; color: #888; margin-top: 4px; }
        .badge-container { display: flex; gap: 8px; flex-wrap: wrap; }
        .badge { padding: 4px 12px; border-radius: 20px; font-size: 11px; font-weight: 600; text-transform: uppercase; }
        .badge-high { background: rgba(244, 67, 54, 0.2); color: #ef5350; border: 1px solid rgba(244, 67, 54, 0.3); }
        .badge-low { background: rgba(33, 150, 243, 0.2); color: #42a5f5; border: 1px solid rgba(33, 150, 243, 0.3); }
        .badge-critical { background: rgba(156, 39, 176, 0.2); color: #ba68c8; border: 1px solid rgba(156, 39, 176, 0.3); }
        .badge-severe { background: rgba(255, 152, 0, 0.2); color: #ffb74d; border: 1px solid rgba(255, 152, 0, 0.3); }
        .badge-moderate { background: rgba(255, 193, 7, 0.2); color: #ffd54f; border: 1px solid rgba(255, 193, 7, 0.3); }
        .section { margin-bottom: 20px; }
        .section-title { font-size: 14px; color: #4a90d9; margin-bottom: 10px; text-transform: uppercase; letter-spacing: 1px; display: flex; align-items: center; gap: 8px; }
        .threshold-grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(120px, 1fr)); gap: 10px; margin-bottom: 15px; }
        .threshold-item { background: rgba(0,0,0,0.2); padding: 10px; border-radius: 8px; text-align: center; }
        .threshold-label { font-size: 11px; color: #888; text-transform: uppercase; margin-bottom: 4px; }
        .threshold-value { font-size: 14px; color: #fff; font-weight: 500; }
        .list-item { padding: 8px 0; border-bottom: 1px solid rgba(255,255,255,0.05); font-size: 14px; line-height: 1.5; }
        .list-item:last-child { border-bottom: none; }
        .back-to-top { position: fixed; bottom: 30px; right: 30px; width: 50px; height: 50px; background: #4a90d9; border: none; border-radius: 50%; color: #fff; font-size: 20px; cursor: pointer; display: none; z-index: 1000; box-shadow: 0 4px 15px rgba(74, 144, 217, 0.4); }
        .back-to-top.show { display: flex; align-items: center; justify-content: center; }
        @media (max-width: 768px) { body { padding: 10px; } .header h1 { font-size: 22px; } .lab-card { padding: 20px; } .threshold-grid { grid-template-columns: repeat(2, 1fr); } }
    </style>
</head>
<body>
    <div class="header">
        <h1>ðŸ”¬ Laboratory Values Clinical Reference</h1>
        <p>Expanded Edition: 100 Laboratory Tests | Evidence-Based Thresholds & Management</p>
    </div>

    <div class="controls">
        <input type="text" class="search-box" id="searchBox" placeholder="Search lab tests, conditions, or keywords...">
        
        <div class="filter-section">
            <div class="filter-label">Category</div>
            <div class="filter-buttons" id="categoryFilters">
                <button class="filter-btn active" data-category="all">All</button>
                <button class="filter-btn" data-category="electrolytes">Electrolytes</button>
                <button class="filter-btn" data-category="cbc">CBC</button>
                <button class="filter-btn" data-category="renal">Renal</button>
                <button class="filter-btn" data-category="hepatic">Hepatic</button>
                <button class="filter-btn" data-category="cardiac">Cardiac</button>
                <button class="filter-btn" data-category="endocrine">Endocrine</button>
                <button class="filter-btn" data-category="coagulation">Coagulation</button>
                <button class="filter-btn" data-category="inflammatory">Inflammatory</button>
                <button class="filter-btn" data-category="iron">Iron Studies</button>
                <button class="filter-btn" data-category="lipids">Lipids</button>
                <button class="filter-btn" data-category="urine">Urine</button>
                <button class="filter-btn" data-category="abg">ABG/Acid-Base</button>
                <button class="filter-btn" data-category="bodyfluid">Body Fluids</button>
                <button class="filter-btn" data-category="infectious">Infectious</button>
                <button class="filter-btn" data-category="tumor">Tumor Markers</button>
                <button class="filter-btn" data-category="drugs">Drug Levels</button>
                <button class="filter-btn" data-category="misc">Miscellaneous</button>
            </div>
        </div>

        <div class="filter-section">
            <div class="filter-label">Direction</div>
            <div class="filter-buttons" id="directionFilters">
                <button class="filter-btn active" data-direction="all">All</button>
                <button class="filter-btn" data-direction="high">â†‘ High</button>
                <button class="filter-btn" data-direction="low">â†“ Low</button>
            </div>
        </div>
    </div>

    <div class="toc-section">
        <button class="toc-toggle" id="tocToggle">
            <span>ðŸ“‹ Table of Contents (100 Laboratory Tests)</span>
            <span>â–¼</span>
        </button>
        <div class="toc-content" id="tocContent">
            <div class="toc-grid" id="tocGrid"></div>
        </div>
    </div>

    <div class="results-info" id="resultsInfo">Showing all laboratory values</div>
    <div class="lab-grid" id="labGrid"></div>
    <button class="back-to-top" id="backToTop">â†‘</button>

    <script>
        const labValues = [
            // ELECTROLYTES (1-14)
            { id: 1, name: "Hyponatremia", subtitle: "Low Sodium", category: "electrolytes", direction: "low", severity: "severe",
                thresholds: { normal: "136-145 mEq/L", mild: "130-135 mEq/L", moderate: "125-129 mEq/L", severe: "120-124 mEq/L", critical: "<120 mEq/L" },
                differential: ["SIADH (malignancy, CNS, pulmonary, drugs)", "Heart failure", "Cirrhosis", "Hypothyroidism", "Adrenal insufficiency", "Psychogenic polydipsia", "Thiazide diuretics", "Beer potomania"],
                management: ["<b>Assess volume status:</b> Hypovolemic vs euvolemic vs hypervolemic", "<b>Check urine Na/osmolality:</b> UNa >20 suggests renal loss or SIADH", "<b>Chronic (>48h):</b> Correct â‰¤8 mEq/L per 24h to prevent ODS", "<b>Acute/symptomatic:</b> 3% saline 100-150mL bolus, recheck Na q2h", "<b>SIADH:</b> Fluid restrict 1-1.5L/day; consider salt tabs, tolvaptan if refractory"]
            },
            { id: 2, name: "Hypernatremia", subtitle: "High Sodium", category: "electrolytes", direction: "high", severity: "severe",
                thresholds: { normal: "136-145 mEq/L", mild: "146-150 mEq/L", moderate: "151-159 mEq/L", severe: "160-169 mEq/L", critical: "â‰¥170 mEq/L" },
                differential: ["Inadequate water intake (elderly, altered mental status)", "Diabetes insipidus (central vs nephrogenic)", "Osmotic diuresis (hyperglycemia, mannitol)", "GI losses (diarrhea)", "Insensible losses (fever, burns)", "Hypertonic saline administration"],
                management: ["<b>Calculate free water deficit:</b> 0.6 Ã— weight(kg) Ã— [(Na/140) - 1]", "<b>Correction rate:</b> â‰¤10-12 mEq/L per 24h to prevent cerebral edema", "<b>Central DI:</b> Desmopressin 1-2 mcg IV/SC q12h", "<b>Nephrogenic DI:</b> Thiazides, amiloride, low-sodium diet", "<b>Replace free water:</b> D5W or 0.45% saline IV; encourage PO if able"]
            },
            { id: 3, name: "Hypokalemia", subtitle: "Low Potassium", category: "electrolytes", direction: "low", severity: "critical",
                thresholds: { normal: "3.5-5.0 mEq/L", mild: "3.0-3.4 mEq/L", moderate: "2.5-2.9 mEq/L", severe: "<2.5 mEq/L", critical: "<2.0 mEq/L" },
                differential: ["Diuretics (loop, thiazide)", "GI losses (vomiting, diarrhea, NG suction)", "Renal tubular acidosis", "Hypomagnesemia", "Hyperaldosteronism", "Refeeding syndrome", "Insulin/beta-agonists (transcellular shift)"],
                management: ["<b>Check Mg:</b> Hypomagnesemia causes refractory hypokalemia - replace Mg first", "<b>Oral replacement:</b> KCl 40-80 mEq PO daily (preferred if able)", "<b>IV replacement:</b> KCl 10-20 mEq/hr via central line (max 40 mEq/hr for critical)", "<b>Cardiac monitoring:</b> Continuous telemetry if K <3.0 or symptomatic", "<b>ECG changes:</b> U waves, flattened T waves, ST depression, arrhythmias"]
            },
            { id: 4, name: "Hyperkalemia", subtitle: "High Potassium", category: "electrolytes", direction: "high", severity: "critical",
                thresholds: { normal: "3.5-5.0 mEq/L", mild: "5.1-5.5 mEq/L", moderate: "5.6-6.0 mEq/L", severe: "6.1-6.5 mEq/L", critical: ">6.5 mEq/L" },
                differential: ["Acute/chronic kidney disease", "ACE inhibitors, ARBs, K-sparing diuretics", "Rhabdomyolysis, tumor lysis syndrome", "Adrenal insufficiency", "Type 4 RTA", "Hemolysis (pseudohyperkalemia)", "Acidosis (transcellular shift)"],
                management: ["<b>ECG immediately:</b> Peaked T waves â†’ widened QRS â†’ sine wave â†’ VF/asystole", "<b>Cardiac membrane stabilization:</b> Calcium gluconate 1-2g IV over 2-5 min", "<b>Shift K intracellularly:</b> Regular insulin 10 units + D50 25g IV; albuterol nebs 10-20mg", "<b>Remove K:</b> Loop diuretics; sodium polystyrene (Kayexalate); patiromer/SZC", "<b>Dialysis:</b> Indicated if refractory, severe, or with AKI"]
            },
            { id: 5, name: "Hypocalcemia", subtitle: "Low Calcium", category: "electrolytes", direction: "low", severity: "severe",
                thresholds: { normal: "8.5-10.5 mg/dL", mild: "7.5-8.4 mg/dL", moderate: "7.0-7.4 mg/dL", severe: "<7.0 mg/dL", critical: "<6.0 mg/dL" },
                differential: ["Hypoparathyroidism (post-surgical)", "Vitamin D deficiency", "Chronic kidney disease", "Hypomagnesemia", "Acute pancreatitis", "Sepsis/critical illness", "Hungry bone syndrome", "Citrate toxicity (massive transfusion)"],
                management: ["<b>Correct for albumin:</b> Corrected Ca = measured Ca + 0.8 Ã— (4 - albumin)", "<b>Check ionized calcium:</b> More accurate in critically ill", "<b>Symptomatic/severe:</b> Calcium gluconate 1-2g IV over 10-20 min; may repeat", "<b>IV infusion:</b> Calcium gluconate 5-10g in 500mL D5W over 4-8h", "<b>Oral:</b> Calcium carbonate 1-2g PO TID + vitamin D supplementation", "<b>Replace magnesium:</b> Hypomagnesemia causes PTH resistance"]
            },
            { id: 6, name: "Hypercalcemia", subtitle: "High Calcium", category: "electrolytes", direction: "high", severity: "severe",
                thresholds: { normal: "8.5-10.5 mg/dL", mild: "10.5-12.0 mg/dL", moderate: "12.1-14.0 mg/dL", severe: "14.1-16.0 mg/dL", critical: ">16.0 mg/dL" },
                differential: ["Primary hyperparathyroidism (90% of outpatient)", "Malignancy - PTHrP, bone mets, myeloma (90% of inpatient)", "Granulomatous disease (sarcoid, TB)", "Vitamin D toxicity", "Thiazide diuretics", "Milk-alkali syndrome", "Immobilization", "Thyrotoxicosis"],
                management: ["<b>Volume resuscitation:</b> NS 200-300 mL/hr initially (4-6L in first 24h)", "<b>Loop diuretic:</b> Furosemide 20-40mg IV after volume replete (promotes calciuresis)", "<b>Bisphosphonate:</b> Zoledronic acid 4mg IV over 15 min (onset 2-4 days)", "<b>Calcitonin:</b> 4 IU/kg SC/IM q12h for rapid effect (tachyphylaxis in 48h)", "<b>Denosumab:</b> For refractory cases or renal impairment", "<b>Dialysis:</b> For severe/refractory with renal failure"]
            },
            { id: 7, name: "Hypomagnesemia", subtitle: "Low Magnesium", category: "electrolytes", direction: "low", severity: "severe",
                thresholds: { normal: "1.7-2.2 mg/dL", mild: "1.4-1.6 mg/dL", moderate: "1.0-1.3 mg/dL", severe: "<1.0 mg/dL", critical: "<0.5 mg/dL" },
                differential: ["Diuretics (loop, thiazide)", "Chronic diarrhea, malabsorption", "Alcoholism", "PPI use (chronic)", "Diabetic ketoacidosis", "Refeeding syndrome", "Aminoglycosides, amphotericin, cisplatin", "Hungry bone syndrome"],
                management: ["<b>Causes refractory hypokalemia and hypocalcemia:</b> Always check Mg with low K or Ca", "<b>Mild-moderate:</b> Magnesium oxide 400-800mg PO BID (poorly absorbed)", "<b>Severe/symptomatic:</b> Magnesium sulfate 1-2g IV over 15-60 min", "<b>Torsades de pointes:</b> Magnesium sulfate 2g IV push", "<b>Maintenance:</b> Magnesium sulfate 4-8g IV over 12-24h", "<b>Renal impairment:</b> Reduce dose and monitor closely for hypermagnesemia"]
            },
            { id: 8, name: "Hypermagnesemia", subtitle: "High Magnesium", category: "electrolytes", direction: "high", severity: "severe",
                thresholds: { normal: "1.7-2.2 mg/dL", mild: "2.3-4.0 mg/dL", moderate: "4.1-6.0 mg/dL", severe: "6.1-10.0 mg/dL", critical: ">10.0 mg/dL" },
                differential: ["Renal failure with Mg-containing antacids/laxatives", "Iatrogenic (excessive Mg replacement)", "Eclampsia treatment", "Adrenal insufficiency", "Tumor lysis syndrome", "Lithium toxicity"],
                management: ["<b>Clinical effects:</b> Hyporeflexia (4-6), respiratory depression (>6), cardiac arrest (>12)", "<b>Stop all Mg-containing products</b>", "<b>Cardiac membrane stabilization:</b> Calcium gluconate 1-2g IV", "<b>Increase renal excretion:</b> NS + furosemide if adequate renal function", "<b>Dialysis:</b> For severe or renal failure"]
            },
            { id: 9, name: "Hypophosphatemia", subtitle: "Low Phosphorus", category: "electrolytes", direction: "low", severity: "severe",
                thresholds: { normal: "2.5-4.5 mg/dL", mild: "2.0-2.4 mg/dL", moderate: "1.0-1.9 mg/dL", severe: "<1.0 mg/dL", critical: "<0.5 mg/dL" },
                differential: ["Refeeding syndrome", "DKA treatment (insulin shifts phos intracellularly)", "Chronic alcoholism", "Respiratory alkalosis", "Vitamin D deficiency", "Hyperparathyroidism", "Phosphate binders", "Hungry bone syndrome"],
                management: ["<b>Severe (<1.0 mg/dL) or symptomatic:</b> IV potassium or sodium phosphate 0.08-0.16 mmol/kg over 6h", "<b>Moderate (1.0-2.0 mg/dL):</b> Oral phosphate 1-2g daily (Neutra-Phos, K-Phos)", "<b>Watch for:</b> Respiratory failure, rhabdomyolysis, hemolysis, cardiac dysfunction", "<b>Refeeding:</b> Start nutrition slowly, monitor phosphate q6-12h initially", "<b>Avoid IV if:</b> Hypercalcemia (precipitation risk)"]
            },
            { id: 10, name: "Hyperphosphatemia", subtitle: "High Phosphorus", category: "electrolytes", direction: "high", severity: "moderate",
                thresholds: { normal: "2.5-4.5 mg/dL", mild: "4.6-5.5 mg/dL", moderate: "5.6-7.0 mg/dL", severe: "7.1-10.0 mg/dL", critical: ">10.0 mg/dL" },
                differential: ["Chronic kidney disease (most common)", "Acute kidney injury", "Tumor lysis syndrome", "Rhabdomyolysis", "Hypoparathyroidism", "Excessive intake (phosphate enemas, supplements)", "Hemolysis (pseudoelevation)"],
                management: ["<b>Dietary restriction:</b> <800-1000 mg/day phosphorus", "<b>Phosphate binders:</b> Calcium acetate, sevelamer, lanthanum - take with meals", "<b>Dialysis:</b> For severe cases with renal failure", "<b>TLS/rhabdo:</b> Aggressive hydration, rasburicase if concurrent hyperuricemia", "<b>Goal in CKD:</b> Maintain phosphorus in normal range; avoid CaÃ—P product >55"]
            },
            { id: 11, name: "Hypochloremia", subtitle: "Low Chloride", category: "electrolytes", direction: "low", severity: "moderate",
                thresholds: { normal: "98-106 mEq/L", mild: "95-97 mEq/L", moderate: "90-94 mEq/L", severe: "<90 mEq/L", critical: "<80 mEq/L" },
                differential: ["Vomiting, NG suction (loss of HCl)", "Metabolic alkalosis", "Diuretic use", "SIADH", "Cystic fibrosis", "Respiratory acidosis compensation", "Heart failure"],
                management: ["<b>Usually accompanies metabolic alkalosis:</b> Treat underlying cause", "<b>Volume depletion:</b> Normal saline resuscitation", "<b>Severe with alkalosis:</b> May need acetazolamide or dilute HCl (rare)", "<b>Address concurrent electrolyte abnormalities</b>"]
            },
            { id: 12, name: "Hyperchloremia", subtitle: "High Chloride", category: "electrolytes", direction: "high", severity: "moderate",
                thresholds: { normal: "98-106 mEq/L", mild: "107-110 mEq/L", moderate: "111-115 mEq/L", severe: ">115 mEq/L", critical: ">120 mEq/L" },
                differential: ["Non-anion gap metabolic acidosis", "Excessive saline administration", "Renal tubular acidosis", "Diarrhea (bicarbonate loss)", "Diabetes insipidus", "Respiratory alkalosis compensation"],
                management: ["<b>Often seen with NAGMA:</b> Calculate anion gap", "<b>Iatrogenic from NS:</b> Switch to balanced crystalloids (LR, Plasmalyte)", "<b>RTA:</b> Sodium bicarbonate supplementation", "<b>Diarrhea:</b> Fluid resuscitation with balanced solutions"]
            },
            { id: 13, name: "Low Bicarbonate", subtitle: "Metabolic Acidosis", category: "electrolytes", direction: "low", severity: "severe",
                thresholds: { normal: "22-28 mEq/L", mild: "18-21 mEq/L", moderate: "15-17 mEq/L", severe: "10-14 mEq/L", critical: "<10 mEq/L" },
                differential: ["<b>Elevated AG (GOLDMARK):</b> Glycols, Oxoproline, L-lactate, D-lactate, Methanol, ASA, Renal failure, Ketoacidosis", "<b>Normal AG:</b> Diarrhea, RTA, early renal failure, acetazolamide, ureteral diversion"],
                management: ["<b>Calculate anion gap:</b> Na - (Cl + HCO3); normal 8-12", "<b>Calculate delta-delta:</b> (AG-12)/(24-HCO3); ~1 pure AGMA, >2 concurrent met alk, <1 concurrent NAGMA", "<b>DKA:</b> Insulin + fluids until AG closes", "<b>Lactic acidosis:</b> Treat underlying cause (sepsis, shock)", "<b>Toxic ingestion:</b> Fomepizole, dialysis for methanol/ethylene glycol", "<b>Bicarb rarely indicated:</b> Consider if pH <7.1 with hemodynamic instability"]
            },
            { id: 14, name: "High Bicarbonate", subtitle: "Metabolic Alkalosis", category: "electrolytes", direction: "high", severity: "moderate",
                thresholds: { normal: "22-28 mEq/L", mild: "29-32 mEq/L", moderate: "33-38 mEq/L", severe: "39-45 mEq/L", critical: ">45 mEq/L" },
                differential: ["<b>Chloride-responsive (UCl <20):</b> Vomiting, NG suction, diuretics (late)", "<b>Chloride-resistant (UCl >20):</b> Hyperaldosteronism, Cushing's, severe hypokalemia, licorice, Bartter/Gitelman"],
                management: ["<b>Check urine chloride:</b> Distinguishes chloride-responsive vs resistant", "<b>Chloride-responsive:</b> NS resuscitation, KCl replacement, hold diuretics", "<b>Chloride-resistant:</b> Treat underlying hyperaldosteronism, K-sparing diuretics", "<b>Severe (pH >7.55):</b> May need acetazolamide 250-500mg IV or dilute HCl"]
            },
            // CBC (15-24)
            { id: 15, name: "Anemia - Low Hemoglobin", subtitle: "Low Hgb/Hct", category: "cbc", direction: "low", severity: "severe",
                thresholds: { normal: "M: 14-18 g/dL, F: 12-16 g/dL", mild: "10-12 g/dL", moderate: "8-10 g/dL", severe: "6.5-8 g/dL", critical: "<6.5 g/dL" },
                differential: ["<b>Microcytic (MCV <80):</b> Iron deficiency, thalassemia, chronic disease, sideroblastic", "<b>Normocytic (MCV 80-100):</b> Acute blood loss, CKD, chronic disease, hemolysis", "<b>Macrocytic (MCV >100):</b> B12/folate deficiency, MDS, liver disease, hypothyroidism, medications"],
                management: ["<b>Check MCV, reticulocyte count, peripheral smear</b>", "<b>Iron deficiency:</b> Ferritin <30, low iron, high TIBC - oral/IV iron replacement", "<b>B12 deficiency:</b> Cyanocobalamin 1000mcg IM daily x7, then weekly x4, then monthly", "<b>Transfusion threshold:</b> Generally Hgb <7 g/dL (or <8 with cardiac disease)", "<b>Active bleeding:</b> Transfuse to maintain hemodynamic stability"]
            },
            { id: 16, name: "Polycythemia", subtitle: "Elevated Hemoglobin/Hematocrit", category: "cbc", direction: "high", severity: "moderate",
                thresholds: { normal: "M: 14-18 g/dL, F: 12-16 g/dL", mild: "M: 18-19, F: 16-17 g/dL", moderate: "M: 19-20, F: 17-18 g/dL", severe: ">20 g/dL", critical: ">22 g/dL" },
                differential: ["<b>Primary:</b> Polycythemia vera (JAK2 mutation)", "<b>Secondary:</b> Chronic hypoxia (COPD, OSA, high altitude), EPO-secreting tumors (RCC, HCC)", "<b>Relative:</b> Dehydration, diuretics, burns"],
                management: ["<b>Check EPO level:</b> Low in PV, high in secondary", "<b>JAK2 V617F mutation:</b> Present in >95% of PV", "<b>PV:</b> Phlebotomy to Hct <45%; aspirin 81mg; hydroxyurea if high-risk", "<b>Secondary:</b> Treat underlying cause (CPAP for OSA, supplemental O2)", "<b>Thrombosis risk:</b> High with Hct >45%"]
            },
            { id: 17, name: "Thrombocytopenia", subtitle: "Low Platelets", category: "cbc", direction: "low", severity: "critical",
                thresholds: { normal: "150-400 K/ÂµL", mild: "100-149 K/ÂµL", moderate: "50-99 K/ÂµL", severe: "20-49 K/ÂµL", critical: "<20 K/ÂµL" },
                differential: ["<b>Decreased production:</b> Marrow infiltration, chemo, aplastic anemia, MDS, B12/folate deficiency", "<b>Increased destruction:</b> ITP, TTP, HIT, DIC, HUS, drugs, infection", "<b>Sequestration:</b> Splenomegaly, cirrhosis", "<b>Dilutional:</b> Massive transfusion"],
                management: ["<b>Review smear:</b> Rule out pseudothrombocytopenia (platelet clumping)", "<b>ITP:</b> IVIG 1g/kg, prednisone 1mg/kg, consider romiplostim if refractory", "<b>TTP:</b> Urgent plasma exchange, avoid platelet transfusion", "<b>HIT:</b> Stop all heparin, start argatroban or bivalirudin, check HIT antibody", "<b>Transfusion threshold:</b> <10K for prophylaxis, <50K for procedures, <100K for neuro/eye surgery"]
            },
            { id: 18, name: "Thrombocytosis", subtitle: "High Platelets", category: "cbc", direction: "high", severity: "moderate",
                thresholds: { normal: "150-400 K/ÂµL", mild: "400-600 K/ÂµL", moderate: "600-1000 K/ÂµL", severe: "1000-1500 K/ÂµL", critical: ">1500 K/ÂµL" },
                differential: ["<b>Reactive (most common):</b> Iron deficiency, infection/inflammation, malignancy, post-splenectomy, chronic blood loss", "<b>Primary:</b> Essential thrombocythemia, polycythemia vera, CML, MDS"],
                management: ["<b>Check iron studies, inflammatory markers, peripheral smear</b>", "<b>Reactive:</b> Treat underlying cause; no antiplatelet needed", "<b>ET:</b> Check JAK2, CALR, MPL mutations; aspirin for low-risk; hydroxyurea for high-risk", "<b>Extreme (>1.5M):</b> Paradoxical bleeding risk due to acquired vWD"]
            },
            { id: 19, name: "Leukocytosis", subtitle: "High WBC", category: "cbc", direction: "high", severity: "moderate",
                thresholds: { normal: "4.5-11.0 K/ÂµL", mild: "11-15 K/ÂµL", moderate: "15-25 K/ÂµL", severe: "25-50 K/ÂµL", critical: ">50 K/ÂµL" },
                differential: ["<b>Neutrophilia:</b> Infection, inflammation, steroids, stress, CML", "<b>Lymphocytosis:</b> Viral infection, CLL, pertussis", "<b>Eosinophilia:</b> Allergies, parasites, drug reaction, hypereosinophilic syndrome", "<b>Monocytosis:</b> Chronic infection, autoimmune, CMML"],
                management: ["<b>Review differential:</b> Identify predominant cell line", "<b>Infection:</b> Cultures, imaging, empiric antibiotics as indicated", "<b>Left shift/bandemia:</b> Suggests acute infection", "<b>Leukemoid reaction:</b> WBC >50K; check smear for blasts â†’ heme consult if present", "<b>Hyperleukocytosis (>100K):</b> Oncologic emergency; hydration, leukapheresis for symptoms"]
            },
            { id: 20, name: "Leukopenia/Neutropenia", subtitle: "Low WBC/ANC", category: "cbc", direction: "low", severity: "critical",
                thresholds: { normal: "ANC 1500-8000/ÂµL", mild: "ANC 1000-1500/ÂµL", moderate: "ANC 500-1000/ÂµL", severe: "ANC 100-500/ÂµL", critical: "ANC <100/ÂµL" },
                differential: ["Chemotherapy/radiation", "Drug-induced (antibiotics, antithyroid, clozapine)", "Viral infections (HIV, EBV, hepatitis)", "Aplastic anemia", "MDS", "Autoimmune (SLE, Felty syndrome)", "Nutritional (B12, folate, copper)"],
                management: ["<b>Neutropenic fever:</b> ANC <500 + fever = emergency; blood cultures, empiric broad-spectrum Abx (cefepime, pip/tazo)", "<b>G-CSF:</b> Filgrastim 5mcg/kg SC daily for chemo-induced", "<b>Infection precautions:</b> Avoid fresh flowers, plants, raw foods", "<b>Low-risk outpatient:</b> Ciprofloxacin + amoxicillin-clavulanate may be appropriate"]
            },
            { id: 21, name: "Elevated MCV", subtitle: "Macrocytosis", category: "cbc", direction: "high", severity: "moderate",
                thresholds: { normal: "80-100 fL", mild: "100-110 fL", moderate: "110-120 fL", severe: ">120 fL", critical: ">130 fL" },
                differential: ["B12 deficiency", "Folate deficiency", "Myelodysplastic syndrome", "Liver disease", "Hypothyroidism", "Medications (methotrexate, hydroxyurea, AZT, phenytoin)", "Reticulocytosis (young RBCs are larger)", "Alcohol use"],
                management: ["<b>Check B12, folate, TSH, LFTs, reticulocyte count</b>", "<b>B12 deficiency:</b> IM cyanocobalamin; check MMA, homocysteine if borderline", "<b>MCV >115:</b> Strongly suggests B12/folate deficiency or MDS", "<b>Liver disease/alcohol:</b> MCV often 100-110 without anemia"]
            },
            { id: 22, name: "Low MCV", subtitle: "Microcytosis", category: "cbc", direction: "low", severity: "moderate",
                thresholds: { normal: "80-100 fL", mild: "75-79 fL", moderate: "70-74 fL", severe: "60-69 fL", critical: "<60 fL" },
                differential: ["Iron deficiency anemia", "Thalassemia trait", "Anemia of chronic disease (sometimes)", "Sideroblastic anemia", "Lead poisoning"],
                management: ["<b>Check iron studies:</b> Ferritin, iron, TIBC, transferrin saturation", "<b>Iron deficiency:</b> Low ferritin (<30), low sat (<20%), high TIBC", "<b>Thalassemia:</b> RBC count often elevated; Mentzer index (MCV/RBC) <13", "<b>Hemoglobin electrophoresis:</b> For suspected thalassemia"]
            },
            { id: 23, name: "Elevated RDW", subtitle: "Red Cell Distribution Width", category: "cbc", direction: "high", severity: "moderate",
                thresholds: { normal: "11.5-14.5%", mild: "14.6-16%", moderate: "16-18%", severe: ">18%", critical: ">20%" },
                differential: ["Iron deficiency anemia", "B12/folate deficiency", "Mixed deficiency anemias", "Myelodysplastic syndrome", "Transfusion", "Early response to iron/B12 replacement", "Hemolysis"],
                management: ["<b>High RDW suggests anisocytosis:</b> Variable RBC sizes", "<b>Iron deficiency:</b> High RDW is early finding, even before MCV drops", "<b>Thalassemia trait:</b> Normal RDW distinguishes from iron deficiency", "<b>Mixed deficiency:</b> Combined iron + B12/folate â†’ very high RDW"]
            },
            { id: 24, name: "Elevated Reticulocyte Count", subtitle: "Reticulocytosis", category: "cbc", direction: "high", severity: "moderate",
                thresholds: { normal: "0.5-2.5%", mild: "2.5-5%", moderate: "5-10%", severe: ">10%", critical: ">15%" },
                differential: ["Hemolytic anemia", "Acute blood loss (response)", "Recovery from marrow suppression", "Response to iron/B12/folate/EPO therapy", "Hemoglobinopathies"],
                management: ["<b>Indicates active RBC production:</b> Appropriate marrow response to anemia", "<b>Calculate reticulocyte index:</b> Retic % Ã— (Hct/45) Ã— (1/maturation factor)", "<b>If elevated with anemia:</b> Points to blood loss or hemolysis", "<b>If low with anemia:</b> Hypoproliferative - marrow problem"]
            },
            // RENAL (25-30)
            { id: 25, name: "Elevated Creatinine", subtitle: "Acute Kidney Injury", category: "renal", direction: "high", severity: "critical",
                thresholds: { normal: "0.7-1.3 mg/dL", mild: "1.3-2.0 mg/dL (or â†‘0.3 from baseline)", moderate: "2.0-4.0 mg/dL", severe: "4.0-8.0 mg/dL", critical: ">8.0 mg/dL" },
                differential: ["<b>Prerenal:</b> Hypovolemia, CHF, cirrhosis, sepsis, NSAIDs, ACEi/ARB", "<b>Intrinsic:</b> ATN (ischemic, nephrotoxic), AIN, glomerulonephritis, contrast", "<b>Postrenal:</b> BPH, stones, tumor, stricture, neurogenic bladder"],
                management: ["<b>FENa:</b> <1% prerenal, >2% ATN (if not on diuretics; use FEUrea if on diuretics)", "<b>Urinalysis:</b> Muddy brown casts (ATN), WBC casts/eosinophils (AIN), RBC casts (GN)", "<b>Renal ultrasound:</b> Hydronephrosis indicates obstruction", "<b>Volume status:</b> Fluid challenge if hypovolemic; diuretics if overloaded", "<b>Stop nephrotoxins:</b> NSAIDs, aminoglycosides, contrast, ACEi/ARB temporarily", "<b>Dialysis indications:</b> AEIOU - Acidosis, Electrolytes (K), Ingestions, Overload, Uremia"]
            },
            { id: 26, name: "Elevated BUN", subtitle: "Blood Urea Nitrogen", category: "renal", direction: "high", severity: "moderate",
                thresholds: { normal: "7-20 mg/dL", mild: "20-40 mg/dL", moderate: "40-80 mg/dL", severe: "80-120 mg/dL", critical: ">120 mg/dL" },
                differential: ["Renal failure (prerenal, intrinsic, postrenal)", "Upper GI bleeding (blood = protein load)", "High protein intake/catabolism", "Dehydration", "Steroids", "Tetracycline"],
                management: ["<b>BUN:Cr ratio:</b> >20:1 suggests prerenal azotemia or GI bleed", "<b>BUN:Cr ratio:</b> ~10-15:1 suggests intrinsic renal disease", "<b>GI bleed:</b> BUN elevated disproportionately to Cr", "<b>Uremic symptoms:</b> Encephalopathy, pericarditis, bleeding â†’ consider dialysis"]
            },
            { id: 27, name: "Low eGFR", subtitle: "Chronic Kidney Disease", category: "renal", direction: "low", severity: "severe",
                thresholds: { normal: ">90 mL/min", G2: "60-89 mL/min", G3a: "45-59 mL/min", G3b: "30-44 mL/min", G4: "15-29 mL/min", G5: "<15 mL/min" },
                differential: ["Diabetic nephropathy", "Hypertensive nephrosclerosis", "Glomerulonephritis", "Polycystic kidney disease", "Obstructive uropathy", "Interstitial nephritis"],
                management: ["<b>Slow progression:</b> ACEi/ARB (proteinuria), SGLT2i, BP control <130/80, glycemic control", "<b>CKD complications:</b> Anemia (EPO), mineral bone disease (phos binders, vitamin D), acidosis (bicarb)", "<b>Avoid nephrotoxins:</b> NSAIDs, contrast (if must use, hydrate pre/post)", "<b>Nephrology referral:</b> eGFR <30 or rapid decline or proteinuria", "<b>Dialysis planning:</b> When eGFR approaches 15-20, discuss RRT options"]
            },
            { id: 28, name: "Proteinuria", subtitle: "Elevated Urine Protein", category: "renal", direction: "high", severity: "moderate",
                thresholds: { normal: "<150 mg/day", microalbuminuria: "30-300 mg/day", overt: "300-3500 mg/day", nephrotic: ">3500 mg/day" },
                differential: ["Diabetic nephropathy", "Hypertensive nephrosclerosis", "Glomerulonephritis (membranous, FSGS, minimal change, IgA)", "Amyloidosis", "Multiple myeloma (light chains)", "Preeclampsia", "Orthostatic proteinuria (benign)"],
                management: ["<b>Quantify:</b> Spot urine protein:creatinine ratio (UPCR) or 24h collection", "<b>ACEi/ARB:</b> First-line to reduce proteinuria (even if normotensive)", "<b>SGLT2 inhibitors:</b> Dapagliflozin, empagliflozin - renoprotective", "<b>Nephrotic syndrome:</b> Edema management, VTE prophylaxis, lipid control, nephrology referral", "<b>Kidney biopsy:</b> Consider if unexplained nephrotic-range or rapidly progressive"]
            },
            { id: 29, name: "Hematuria", subtitle: "Blood in Urine", category: "renal", direction: "high", severity: "moderate",
                thresholds: { normal: "<3 RBC/hpf", microscopic: "3-10 RBC/hpf", moderate: "10-50 RBC/hpf", severe: ">50 RBC/hpf", gross: "Visible blood" },
                differential: ["<b>Glomerular:</b> IgA nephropathy, thin basement membrane, Alport, post-infectious GN (dysmorphic RBCs, casts)", "<b>Non-glomerular:</b> UTI, stones, malignancy (bladder, renal, prostate), BPH, trauma, exercise"],
                management: ["<b>Urinalysis:</b> Dysmorphic RBCs/RBC casts suggest glomerular source", "<b>Age >35 or risk factors:</b> Urology referral for malignancy workup (cystoscopy, CT urogram)", "<b>Glomerular suspected:</b> Check creatinine, complement, ANA, ANCA; nephrology referral", "<b>Concurrent proteinuria:</b> More concerning for glomerular disease", "<b>Anticoagulation:</b> Still requires workup - don't attribute solely to blood thinners"]
            },
            { id: 30, name: "Urine Sodium/FENa", subtitle: "Fractional Excretion", category: "renal", direction: "low", severity: "moderate",
                thresholds: { prerenal: "FENa <1%, UNa <20", intrinsic: "FENa >2%, UNa >40", overlap: "FENa 1-2%" },
                differential: ["<b>FENa <1%:</b> Prerenal (volume depletion, CHF, cirrhosis), early obstruction, contrast nephropathy, rhabdomyolysis, acute GN", "<b>FENa >2%:</b> ATN, AIN, post-obstructive, CKD"],
                management: ["<b>Calculate FENa:</b> (UNa Ã— PCr) / (PNa Ã— UCr) Ã— 100", "<b>On diuretics:</b> Use FEUrea instead - <35% prerenal, >50% intrinsic", "<b>Prerenal:</b> Fluid resuscitation; hold diuretics, NSAIDs, ACEi/ARB", "<b>ATN:</b> Supportive care; recovery typically 1-3 weeks", "<b>Limitations:</b> Less accurate in CKD, cirrhosis, or ongoing diuretic use"]
            },
            // HEPATIC (31-40)
            { id: 31, name: "Elevated AST/ALT", subtitle: "Transaminases", category: "hepatic", direction: "high", severity: "severe",
                thresholds: { normal: "<40 U/L", mild: "40-200 U/L (<5Ã— ULN)", moderate: "200-1000 U/L (5-25Ã— ULN)", severe: ">1000 U/L (>25Ã— ULN)", critical: ">3000 U/L" },
                differential: ["<b>AST/ALT >1000:</b> Ischemic hepatitis (shock liver), acetaminophen toxicity, acute viral hepatitis, acute Budd-Chiari", "<b>AST>ALT (2:1):</b> Alcoholic hepatitis, cirrhosis, Wilson's", "<b>ALT>AST:</b> NAFLD, chronic viral hepatitis, medications", "<b>Isolated AST:</b> Muscle injury (rhabdomyolysis, MI), hemolysis"],
                management: ["<b>Check:</b> Bilirubin, INR, albumin for synthetic function", "<b>Acetaminophen level:</b> If any suspicion; N-acetylcysteine if positive", "<b>Viral hepatitis:</b> HAV IgM, HBsAg, HBc IgM, HCV Ab, HCV RNA", "<b>Ischemic hepatitis:</b> Often ALT >1000 with rapid rise/fall; treat underlying shock", "<b>Hepatology consult:</b> ALT >1000, synthetic dysfunction, or suspected acute liver failure"]
            },
            { id: 32, name: "Elevated Bilirubin", subtitle: "Hyperbilirubinemia", category: "hepatic", direction: "high", severity: "severe",
                thresholds: { normal: "0.1-1.2 mg/dL", mild: "1.2-3.0 mg/dL", moderate: "3.0-10.0 mg/dL", severe: "10-20 mg/dL", critical: ">20 mg/dL" },
                differential: ["<b>Unconjugated (indirect):</b> Hemolysis, Gilbert's, ineffective erythropoiesis, heart failure", "<b>Conjugated (direct):</b> Hepatocellular injury, cholestasis, biliary obstruction", "<b>Mixed:</b> Sepsis, TPN, drugs"],
                management: ["<b>Fractionate bilirubin:</b> Direct (conjugated) vs indirect (unconjugated)", "<b>Direct >50%:</b> Cholestatic - check ALP, GGT; get RUQ ultrasound for stones/dilation", "<b>Indirect predominant:</b> Check hemolysis labs (LDH, haptoglobin, retic, smear)", "<b>Biliary obstruction:</b> ERCP for common bile duct stones; percutaneous drainage if ERCP fails", "<b>Drug-induced:</b> Review medications; discontinue offending agent"]
            },
            { id: 33, name: "Elevated Alkaline Phosphatase", subtitle: "ALP", category: "hepatic", direction: "high", severity: "moderate",
                thresholds: { normal: "44-147 U/L", mild: "1-2Ã— ULN", moderate: "2-5Ã— ULN", severe: ">5Ã— ULN", critical: ">10Ã— ULN" },
                differential: ["<b>Hepatic:</b> Biliary obstruction, cholestatic drugs, PBC, PSC, infiltrative disease", "<b>Bone:</b> Paget's, bone mets, fractures, hyperparathyroidism, osteomalacia", "<b>Other:</b> Pregnancy (placental), malignancy, hyperthyroidism"],
                management: ["<b>Confirm hepatic source:</b> Check GGT (if also elevated â†’ hepatic origin)", "<b>If isolated ALP:</b> Bone source - check calcium, PTH, vitamin D", "<b>Cholestatic pattern (ALP/ALT >2):</b> RUQ US â†’ MRCP if dilated ducts or no stones", "<b>PBC:</b> Check AMA; if positive, consider ursodiol", "<b>PSC:</b> Check MRCP; associated with IBD"]
            },
            { id: 34, name: "Elevated GGT", subtitle: "Gamma-Glutamyl Transferase", category: "hepatic", direction: "high", severity: "moderate",
                thresholds: { normal: "0-51 U/L", mild: "51-150 U/L", moderate: "150-500 U/L", severe: ">500 U/L" },
                differential: ["Alcohol use (very sensitive marker)", "Cholestatic liver disease", "Fatty liver disease (NAFLD)", "Medications (phenytoin, barbiturates)", "Pancreatic disease", "Cardiac disease"],
                management: ["<b>Primarily used to confirm hepatic source of elevated ALP</b>", "<b>Elevated GGT + ALP:</b> Hepatobiliary source confirmed", "<b>Alcohol:</b> GGT very sensitive but not specific for alcohol use", "<b>If isolated GGT elevation:</b> Less clinically significant; consider alcohol, meds, NAFLD"]
            },
            { id: 35, name: "Low Albumin", subtitle: "Hypoalbuminemia", category: "hepatic", direction: "low", severity: "severe",
                thresholds: { normal: "3.5-5.0 g/dL", mild: "3.0-3.4 g/dL", moderate: "2.5-2.9 g/dL", severe: "2.0-2.4 g/dL", critical: "<2.0 g/dL" },
                differential: ["Chronic liver disease/cirrhosis", "Malnutrition", "Nephrotic syndrome", "Protein-losing enteropathy", "Acute inflammation/critical illness (negative acute phase reactant)", "Burns", "Sepsis"],
                management: ["<b>Reflects synthetic function:</b> Half-life ~20 days (slower decline than INR)", "<b>Liver disease:</b> Poor prognostic marker; part of MELD, Child-Pugh", "<b>Edema management:</b> Loop diuretics +/- albumin infusion", "<b>Correct calcium:</b> Add 0.8 for each 1 g/dL albumin below 4.0", "<b>SBP prophylaxis:</b> Consider if albumin <1.5 g/dL in cirrhosis"]
            },
            { id: 36, name: "Elevated Ammonia", subtitle: "Hyperammonemia", category: "hepatic", direction: "high", severity: "severe",
                thresholds: { normal: "15-45 Âµg/dL", mild: "45-75 Âµg/dL", moderate: "75-150 Âµg/dL", severe: "150-300 Âµg/dL", critical: ">300 Âµg/dL" },
                differential: ["Hepatic encephalopathy (cirrhosis, acute liver failure)", "Portosystemic shunting (TIPS, portal HTN)", "GI bleeding (protein load)", "Urea cycle disorders", "Urease-producing UTI", "Valproic acid toxicity"],
                management: ["<b>Note:</b> Ammonia level does not always correlate with HE severity", "<b>Lactulose:</b> 30mL PO q2-3h until bowel movement, then titrate to 2-3 soft BMs/day", "<b>Rifaximin:</b> 550mg PO BID for recurrent HE", "<b>Identify precipitant:</b> GI bleed, infection, constipation, electrolyte abnormalities, sedatives", "<b>Protein:</b> Do NOT restrict - maintain 1.2-1.5 g/kg/day"]
            },
            { id: 37, name: "Elevated INR - Liver Disease", subtitle: "Coagulopathy", category: "hepatic", direction: "high", severity: "severe",
                thresholds: { normal: "0.8-1.2", mild: "1.2-1.5", moderate: "1.5-2.0", severe: "2.0-2.5", critical: ">2.5" },
                differential: ["Acute liver failure", "Cirrhosis/chronic liver disease", "Vitamin K deficiency (malnutrition, malabsorption, antibiotics)", "DIC", "Warfarin/anticoagulants"],
                management: ["<b>Reflects synthetic function:</b> Half-life ~6 hours (rises quickly in acute failure)", "<b>Vitamin K trial:</b> 10mg IV/PO Ã— 3 days - if corrects, suggests vitamin K deficiency", "<b>Vitamin K does NOT correct:</b> Liver-related coagulopathy", "<b>FFP:</b> Only for active bleeding or pre-procedure (transient effect)", "<b>Acute liver failure:</b> INR is key prognostic marker; hepatology/transplant consultation"]
            },
            { id: 38, name: "Elevated Lipase", subtitle: "Acute Pancreatitis", category: "hepatic", direction: "high", severity: "severe",
                thresholds: { normal: "0-160 U/L", elevated: ">3Ã— ULN diagnostic", mild: "3-5Ã— ULN", moderate: "5-10Ã— ULN", severe: ">10Ã— ULN" },
                differential: ["Acute pancreatitis (gallstones, alcohol, hypertriglyceridemia, drugs, ERCP)", "Pancreatic malignancy", "Renal failure (decreased clearance)", "Bowel obstruction/perforation", "Cholecystitis"],
                management: ["<b>Diagnosis:</b> Lipase >3Ã— ULN + characteristic pain (Â±CT findings)", "<b>Lipase level does NOT correlate with severity</b>", "<b>Initial management:</b> NPO, aggressive IVF (250-500mL/hr initially), pain control", "<b>Severity scoring:</b> BISAP, Ranson's, APACHE II; CT for necrosis if no improvement in 48-72h", "<b>Etiology workup:</b> RUQ US (gallstones), triglycerides, calcium, medication review", "<b>Gallstone pancreatitis:</b> Cholecystectomy during same admission if mild"]
            },
            { id: 39, name: "Ascitic Fluid Analysis", subtitle: "Paracentesis", category: "hepatic", direction: "high", severity: "severe",
                thresholds: { SAAG: "â‰¥1.1 = portal HTN", PMN: ">250 = SBP", protein: "<2.5 = low gradient" },
                differential: ["<b>SAAG â‰¥1.1:</b> Cirrhosis, heart failure, Budd-Chiari, portal vein thrombosis", "<b>SAAG <1.1:</b> Malignancy, TB peritonitis, nephrotic syndrome, pancreatitis"],
                management: ["<b>Calculate SAAG:</b> Serum albumin - ascites albumin", "<b>SBP diagnosis:</b> PMN >250/mmÂ³ (regardless of culture)", "<b>SBP treatment:</b> Ceftriaxone 2g IV daily Ã— 5 days; albumin 1.5g/kg day 1, 1g/kg day 3", "<b>SBP prophylaxis:</b> Prior SBP, GI bleed, or ascites protein <1.5 â†’ ciprofloxacin or TMP-SMX", "<b>Diuretics:</b> Spironolactone:furosemide 100:40 ratio; max spiro 400mg/day"]
            },
            { id: 40, name: "Elevated Procalcitonin", subtitle: "Bacterial Infection Marker", category: "inflammatory", direction: "high", severity: "moderate",
                thresholds: { normal: "<0.1 ng/mL", low: "0.1-0.25 ng/mL", intermediate: "0.25-0.5 ng/mL", high: "0.5-2.0 ng/mL", veryhigh: ">2.0 ng/mL" },
                differential: ["Bacterial infection/sepsis", "Pneumonia (bacterial)", "Post-surgical", "Severe trauma/burns", "Cardiogenic shock", "Some malignancies"],
                management: ["<b><0.25:</b> Bacterial infection unlikely; consider stopping/not starting antibiotics", "<b>0.25-0.5:</b> Possible bacterial infection; clinical judgment", "<b>>0.5:</b> Bacterial infection likely; start/continue antibiotics", "<b>>2.0:</b> Severe bacterial infection/sepsis highly likely", "<b>Trending:</b> Can help guide antibiotic duration (stop when <0.25 or 80% drop)"]
            },
            // CARDIAC (41-45)
            { id: 41, name: "Elevated Troponin", subtitle: "Myocardial Injury", category: "cardiac", direction: "high", severity: "critical",
                thresholds: { normal: "<0.04 ng/mL (or <99th percentile)", mild: "1-3Ã— ULN", moderate: "3-10Ã— ULN", severe: ">10Ã— ULN", critical: ">100Ã— ULN" },
                differential: ["<b>Type 1 MI:</b> Plaque rupture/thrombosis (ACS)", "<b>Type 2 MI:</b> Supply-demand mismatch (tachycardia, hypotension, anemia, hypoxia)", "<b>Non-ischemic:</b> Myocarditis, PE, heart failure, sepsis, renal failure, Takotsubo", "<b>Chronic elevation:</b> CKD, structural heart disease"],
                management: ["<b>Clinical context is critical:</b> Troponin alone does not diagnose MI", "<b>Serial troponins:</b> Check q3-6h; rise-and-fall pattern suggests acute injury", "<b>Type 1 MI (ACS):</b> Antiplatelet, anticoagulation, cardiology consult, consider cath", "<b>Type 2 MI:</b> Treat underlying cause (rate control, transfusion, supplemental O2)", "<b>ECG:</b> Essential adjunct; STEMI = emergent cath"]
            },
            { id: 42, name: "Elevated BNP/NT-proBNP", subtitle: "Heart Failure Marker", category: "cardiac", direction: "high", severity: "severe",
                thresholds: { BNP_normal: "<100 pg/mL", BNP_gray: "100-400 pg/mL", BNP_elevated: ">400 pg/mL", NTproBNP_normal: "<300 pg/mL", NTproBNP_elevated: ">450-1800 pg/mL (age-dependent)" },
                differential: ["Heart failure (systolic or diastolic)", "Acute coronary syndrome", "Pulmonary embolism", "Pulmonary hypertension", "Atrial fibrillation", "Renal failure (decreased clearance)", "Sepsis", "High-output states"],
                management: ["<b>Diagnosis:</b> BNP <100 or NT-proBNP <300 makes HF very unlikely", "<b>BNP >400 or NT-proBNP >900-1800:</b> Strongly suggests HF", "<b>Obesity:</b> Falsely low natriuretic peptides", "<b>CKD:</b> Chronically elevated; use higher cutoffs", "<b>Prognosis:</b> Higher levels = worse outcomes; useful for trending", "<b>Acute HF treatment:</b> Diuretics, afterload reduction, address precipitant"]
            },
            { id: 43, name: "Elevated D-Dimer", subtitle: "Fibrin Degradation Product", category: "cardiac", direction: "high", severity: "moderate",
                thresholds: { normal: "<500 ng/mL (or age-adjusted: age Ã— 10 if >50)", mild: "500-1000 ng/mL", moderate: "1000-4000 ng/mL", severe: ">4000 ng/mL" },
                differential: ["Venous thromboembolism (DVT, PE)", "DIC", "Sepsis/infection", "Malignancy", "Recent surgery/trauma", "Pregnancy", "Liver disease", "Atrial fibrillation", "Aortic dissection"],
                management: ["<b>High sensitivity, low specificity:</b> Good for ruling OUT VTE if low pretest probability", "<b>Age-adjusted cutoff (>50 years):</b> Age Ã— 10 ng/mL", "<b>If elevated with high suspicion:</b> Imaging required (CTA for PE, US for DVT)", "<b>Very high levels:</b> Consider DIC, massive PE, dissection", "<b>Do NOT use to rule out VTE in high-risk patients:</b> Image directly"]
            },
            { id: 44, name: "Elevated CK/CK-MB", subtitle: "Creatine Kinase", category: "cardiac", direction: "high", severity: "severe",
                thresholds: { normal: "30-200 U/L", mild: "200-1000 U/L", moderate: "1000-5000 U/L", severe: "5000-20000 U/L", critical: ">20000 U/L (rhabdo)" },
                differential: ["Rhabdomyolysis (trauma, exercise, drugs, statins, seizures)", "Myocardial infarction (CK-MB)", "Muscle disease (myositis, dystrophy)", "Hypothyroidism", "Medications (statins, fibrates, colchicine)", "Vigorous exercise"],
                management: ["<b>CK-MB:</b> Less specific than troponin for MI; largely replaced", "<b>Rhabdomyolysis (CK >5Ã— ULN with AKI):</b> Aggressive IVF (200-300 mL/hr), target UOP 200-300 mL/hr", "<b>Monitor for:</b> Hyperkalemia, hypocalcemia, compartment syndrome", "<b>Statin-induced:</b> Hold statin; consider switching class or lower dose", "<b>Serial CK:</b> Follow to ensure downtrending"]
            },
            { id: 45, name: "Elevated Lactate", subtitle: "Lactic Acidosis", category: "cardiac", direction: "high", severity: "critical",
                thresholds: { normal: "0.5-2.0 mmol/L", mild: "2.0-4.0 mmol/L", moderate: "4.0-8.0 mmol/L", severe: ">8.0 mmol/L", critical: ">10 mmol/L" },
                differential: ["<b>Type A (hypoperfusion):</b> Sepsis, cardiogenic shock, hemorrhage, mesenteric ischemia, limb ischemia", "<b>Type B (non-hypoperfusion):</b> Metformin, liver failure, malignancy, seizures, thiamine deficiency, propofol infusion, linezolid"],
                management: ["<b>Type A:</b> Aggressive resuscitation; identify and treat cause of hypoperfusion", "<b>Sepsis:</b> Lactate clearance (decrease >10% in 2-4h) is prognostic marker", "<b>Metformin-associated:</b> Hold metformin; dialysis for severe acidosis", "<b>Thiamine deficiency:</b> Give thiamine 100mg IV empirically in alcoholics, malnourished", "<b>Trending:</b> Lactate clearance is more important than absolute value"]
            },
            // ENDOCRINE (46-55)
            { id: 46, name: "Hyperglycemia/DKA/HHS", subtitle: "Elevated Glucose", category: "endocrine", direction: "high", severity: "critical",
                thresholds: { normal: "70-100 mg/dL fasting", elevated: "100-200 mg/dL", high: "200-400 mg/dL", DKA: ">250 with ketones/acidosis", HHS: ">600 mg/dL" },
                differential: ["Uncontrolled/undiagnosed diabetes", "DKA (usually type 1; infection, missed insulin)", "HHS (type 2, elderly, severe dehydration)", "Stress hyperglycemia (illness, steroids)", "Medications (steroids, atypicals)"],
                management: ["<b>DKA:</b> IVF (NS then 0.45% when Na normalizes), insulin drip (0.1 U/kg/hr), K replacement (if K <5.3), monitor AG q2-4h", "<b>HHS:</b> Aggressive fluids (6-9L deficit); insulin less critical early; correct Na gradually", "<b>Transition to SQ:</b> When eating, AG closed, bicarb >18; overlap insulin drip 1-2h", "<b>Identify precipitant:</b> Infection, MI, medication non-compliance, new-onset DM"]
            },
            { id: 47, name: "Hypoglycemia", subtitle: "Low Glucose", category: "endocrine", direction: "low", severity: "critical",
                thresholds: { normal: "70-100 mg/dL", mild: "55-70 mg/dL", moderate: "40-54 mg/dL", severe: "<40 mg/dL", critical: "<30 mg/dL" },
                differential: ["Insulin/sulfonylurea excess", "Missed meals", "Alcohol", "Sepsis", "Adrenal insufficiency", "Insulinoma", "Non-islet cell tumor", "Renal/hepatic failure"],
                management: ["<b>Rule of 15:</b> 15g fast-acting carbs, recheck in 15 min", "<b>IV dextrose:</b> D50 25-50mL (12.5-25g) IV push if unable to take PO", "<b>Glucagon:</b> 1mg IM/SC if no IV access", "<b>Sulfonylurea overdose:</b> Octreotide 50-100mcg SC q8h (prevents insulin release)", "<b>Whipple's triad:</b> Symptoms + low glucose + resolution with treatment = true hypoglycemia"]
            },
            { id: 48, name: "Elevated TSH", subtitle: "Hypothyroidism", category: "endocrine", direction: "high", severity: "moderate",
                thresholds: { normal: "0.5-4.5 mIU/L", subclinical: "4.5-10 mIU/L", overt: "10-50 mIU/L", severe: ">50 mIU/L", myxedema: ">100 mIU/L + symptoms" },
                differential: ["Primary hypothyroidism (Hashimoto's, post-ablation, post-thyroidectomy, drugs)", "Recovery from thyroiditis", "TSH-secreting pituitary adenoma (rare)", "Thyroid hormone resistance (rare)"],
                management: ["<b>Check free T4:</b> Low = overt hypothyroidism; normal = subclinical", "<b>Levothyroxine:</b> Start 1.6 mcg/kg/day for overt; 25-50 mcg/day if elderly or cardiac disease", "<b>Myxedema coma:</b> IV levothyroxine 200-500mcg loading, then 50-100mcg/day; stress-dose steroids until AI ruled out", "<b>Recheck TSH:</b> 6-8 weeks after dose change", "<b>Drug-induced:</b> Lithium, amiodarone, immune checkpoint inhibitors"]
            },
            { id: 49, name: "Low TSH", subtitle: "Hyperthyroidism", category: "endocrine", direction: "low", severity: "severe",
                thresholds: { normal: "0.5-4.5 mIU/L", suppressed: "0.1-0.5 mIU/L", overt: "<0.1 mIU/L", thyroidstorm: "<0.01 mIU/L + symptoms" },
                differential: ["Graves' disease", "Toxic multinodular goiter", "Toxic adenoma", "Thyroiditis (subacute, postpartum, painless)", "Exogenous thyroid hormone", "Amiodarone-induced", "Central hypothyroidism (low TSH + low T4)"],
                management: ["<b>Check free T4, T3:</b> Elevated = overt hyperthyroidism", "<b>Mild/moderate:</b> Methimazole 10-30mg/day (preferred); PTU for pregnancy 1st trimester or thyroid storm", "<b>Thyroid storm:</b> PTU 500-1000mg load â†’ 250mg q4h; propranolol; iodine (after PTU); hydrocortisone 100mg q8h", "<b>Beta-blocker:</b> Propranolol 10-40mg q6h for symptom control", "<b>Radioiodine or surgery:</b> Definitive treatment options"]
            },
            { id: 50, name: "Low Cortisol/Adrenal Insufficiency", subtitle: "Hypocortisolism", category: "endocrine", direction: "low", severity: "critical",
                thresholds: { normal_AM: "10-20 Âµg/dL", suggestive: "<10 Âµg/dL AM", definite: "<3 Âµg/dL AM", crisis: "Hemodynamic instability + low cortisol" },
                differential: ["Primary (Addison's): Autoimmune, infection (TB, CMV, fungal), hemorrhage, metastases", "Secondary: Pituitary disease, prolonged steroid use then abrupt withdrawal", "Critical illness-related corticosteroid insufficiency"],
                management: ["<b>Cosyntropin stim test:</b> Cortisol <18-20 at 30-60 min confirms diagnosis", "<b>Crisis:</b> Hydrocortisone 100mg IV bolus â†’ 50mg IV q6h or 200mg/24h infusion", "<b>Chronic:</b> Hydrocortisone 15-25mg/day (2/3 AM, 1/3 PM) Â± fludrocortisone 0.1mg/day", "<b>Stress dosing:</b> Double/triple dose during illness", "<b>Medical alert bracelet:</b> Essential for all patients"]
            },
            { id: 51, name: "Elevated Cortisol", subtitle: "Cushing's Syndrome", category: "endocrine", direction: "high", severity: "moderate",
                thresholds: { normal_AM: "10-20 Âµg/dL", suspicious: "Abnormal screening tests", confirmed: "Multiple abnormal tests" },
                differential: ["ACTH-dependent: Pituitary adenoma (Cushing's disease), ectopic ACTH (lung cancer)", "ACTH-independent: Adrenal adenoma, adrenal carcinoma", "Exogenous steroids (most common cause of Cushingoid features)", "Pseudo-Cushing's: Alcohol, depression, obesity"],
                management: ["<b>Screening:</b> 24h urine free cortisol (>3Ã— ULN), late-night salivary cortisol, 1mg DST (cortisol >1.8)", "<b>Confirm with:</b> At least 2 abnormal screening tests", "<b>Localize:</b> Check ACTH; if high â†’ pituitary MRI, if low â†’ adrenal CT", "<b>Treatment:</b> Surgical resection is primary treatment", "<b>Manage complications:</b> Glucose, BP, osteoporosis, infections"]
            },
            { id: 52, name: "Elevated PTH", subtitle: "Hyperparathyroidism", category: "endocrine", direction: "high", severity: "moderate",
                thresholds: { normal: "15-65 pg/mL", elevated: ">65 pg/mL", primary: "High PTH + high calcium", secondary: "High PTH + low/normal calcium" },
                differential: ["Primary hyperparathyroidism: Adenoma (85%), hyperplasia (15%), carcinoma (rare)", "Secondary: CKD, vitamin D deficiency", "Tertiary: Autonomous after prolonged secondary"],
                management: ["<b>Primary:</b> Check 24h urine calcium (rule out FHH), DEXA, renal function", "<b>Surgery indications:</b> Ca >1 above normal, age <50, T-score <-2.5, eGFR <60, kidney stones", "<b>Medical management:</b> Hydration, avoid thiazides, cinacalcet if surgery not possible", "<b>Secondary:</b> Phosphate binders, vitamin D, calcimimetics", "<b>Tertiary:</b> Often requires parathyroidectomy"]
            },
            { id: 53, name: "Low PTH", subtitle: "Hypoparathyroidism", category: "endocrine", direction: "low", severity: "severe",
                thresholds: { normal: "15-65 pg/mL", low: "<15 pg/mL", undetectable: "<6 pg/mL" },
                differential: ["Post-surgical (most common - thyroidectomy, parathyroidectomy)", "Autoimmune", "Infiltrative (hemochromatosis, Wilson's)", "Hypomagnesemia (impairs PTH secretion)", "DiGeorge syndrome"],
                management: ["<b>Presentation:</b> Hypocalcemia symptoms (tetany, Chvostek's, Trousseau's, seizures)", "<b>Acute:</b> Calcium gluconate 1-2g IV over 10-20 min", "<b>Chronic:</b> Calcium carbonate 1-3g/day + calcitriol 0.25-1 mcg/day", "<b>Monitor:</b> Keep calcium low-normal to avoid hypercalciuria/nephrolithiasis", "<b>Replace magnesium:</b> Hypomagnesemia causes PTH resistance"]
            },
            { id: 54, name: "Elevated HbA1c", subtitle: "Glycated Hemoglobin", category: "endocrine", direction: "high", severity: "moderate",
                thresholds: { normal: "<5.7%", prediabetes: "5.7-6.4%", diabetes: "â‰¥6.5%", poorcontrol: ">9%", veryhigh: ">12%" },
                differential: ["Type 1 diabetes", "Type 2 diabetes", "Secondary diabetes (steroids, pancreatitis, hemochromatosis)", "Conditions causing falsely elevated HbA1c: Iron deficiency, asplenia, renal failure"],
                management: ["<b>Target for most adults:</b> <7%", "<b>Less stringent (7.5-8%):</b> Elderly, limited life expectancy, hypoglycemia risk, advanced complications", "<b>More stringent (<6.5%):</b> Newly diagnosed, long life expectancy, no CVD", "<b>Falsely low:</b> Hemolysis, blood loss, EPO, hemoglobinopathies", "<b>Review:</b> Recheck every 3 months if above goal; every 6 months if at goal"]
            },
            { id: 55, name: "Low Vitamin D", subtitle: "Vitamin D Deficiency", category: "endocrine", direction: "low", severity: "moderate",
                thresholds: { optimal: "30-100 ng/mL", insufficient: "20-29 ng/mL", deficient: "12-19 ng/mL", severe: "<12 ng/mL" },
                differential: ["Inadequate sun exposure", "Dietary deficiency", "Malabsorption (celiac, IBD, gastric bypass)", "Chronic kidney disease", "Liver disease", "Medications (phenytoin, phenobarbital)"],
                management: ["<b>Severe deficiency:</b> Vitamin D2 or D3 50,000 IU weekly Ã— 8-12 weeks, then maintenance", "<b>Moderate deficiency:</b> Vitamin D3 2000-4000 IU daily", "<b>Maintenance:</b> 1000-2000 IU daily", "<b>CKD:</b> Often need active vitamin D (calcitriol) due to impaired 1-alpha-hydroxylation", "<b>Recheck:</b> 25-OH vitamin D in 8-12 weeks"]
            },
            // COAGULATION (56-62)
            { id: 56, name: "Elevated PT/INR", subtitle: "Prolonged Prothrombin Time", category: "coagulation", direction: "high", severity: "severe",
                thresholds: { normal: "PT 11-13.5s, INR 0.8-1.2", mild: "INR 1.2-2.0", moderate: "INR 2.0-4.0", severe: "INR 4.0-10", critical: "INR >10" },
                differential: ["Warfarin therapy", "Vitamin K deficiency", "Liver disease", "DIC", "Factor VII deficiency", "Supratherapeutic anticoagulation"],
                management: ["<b>Warfarin goal:</b> INR 2-3 for most indications; 2.5-3.5 for mechanical valves", "<b>Supratherapeutic + no bleeding:</b> Hold warfarin; vitamin K 2.5-5mg PO if INR >9", "<b>Major bleeding:</b> 4-factor PCC (25-50 U/kg) + vitamin K 10mg IV; FFP if PCC unavailable", "<b>Liver disease:</b> INR does NOT reflect bleeding risk well; consider TEG/ROTEM", "<b>Vitamin K deficiency:</b> 10mg IV/PO Ã— 3 days"]
            },
            { id: 57, name: "Elevated PTT", subtitle: "Prolonged Activated PTT", category: "coagulation", direction: "high", severity: "severe",
                thresholds: { normal: "25-35 seconds", mild: "35-50s", moderate: "50-80s", severe: "80-120s", critical: ">120s" },
                differential: ["Heparin therapy", "Factor VIII/IX/XI/XII deficiency", "von Willebrand disease", "Lupus anticoagulant", "DIC", "Hemophilia A or B"],
                management: ["<b>Mixing study:</b> Corrects = factor deficiency; doesn't correct = inhibitor (LA, factor inhibitor)", "<b>Heparin monitoring:</b> Target aPTT 1.5-2.5Ã— control for therapeutic anticoagulation", "<b>Lupus anticoagulant:</b> Paradoxically increases thrombosis risk", "<b>Hemophilia:</b> Factor replacement; hematology consult", "<b>Heparin reversal:</b> Protamine 1mg per 100U heparin (last 2-3h)"]
            },
            { id: 58, name: "Elevated Fibrinogen", subtitle: "Hyperfibrinogenemia", category: "coagulation", direction: "high", severity: "moderate",
                thresholds: { normal: "200-400 mg/dL", elevated: "400-700 mg/dL", high: ">700 mg/dL" },
                differential: ["Acute phase reactant (infection, inflammation, malignancy)", "Pregnancy", "Smoking", "Oral contraceptives", "Nephrotic syndrome"],
                management: ["<b>Acute phase reactant:</b> Elevated in inflammatory states", "<b>Thrombosis risk:</b> May be mildly increased with very high levels", "<b>Generally:</b> No specific treatment needed; address underlying cause"]
            },
            { id: 59, name: "Low Fibrinogen", subtitle: "Hypofibrinogenemia", category: "coagulation", direction: "low", severity: "critical",
                thresholds: { normal: "200-400 mg/dL", low: "100-200 mg/dL", severe: "50-100 mg/dL", critical: "<50 mg/dL" },
                differential: ["DIC (most common acquired cause)", "Liver disease/failure", "Massive transfusion/dilution", "Thrombolytic therapy", "Congenital afibrinogenemia", "L-asparaginase"],
                management: ["<b>DIC workup:</b> Check D-dimer, PT, PTT, platelets, smear", "<b>Replacement:</b> Cryoprecipitate (10 units raises fibrinogen ~50mg/dL)", "<b>Target:</b> Fibrinogen >100-150 mg/dL for active bleeding", "<b>FFP:</b> Contains fibrinogen but large volume needed", "<b>Fibrinogen concentrate:</b> Alternative to cryo (RiaSTAP)"]
            },
            { id: 60, name: "DIC Panel", subtitle: "Disseminated Intravascular Coagulation", category: "coagulation", direction: "high", severity: "critical",
                thresholds: { criteria: "Platelets â†“, fibrinogen â†“, D-dimer â†‘, PT/PTT â†‘, schistocytes on smear" },
                differential: ["<b>Overt DIC triggers:</b> Sepsis, trauma, malignancy (APL, adenocarcinoma), obstetric complications, massive transfusion, burns", "<b>Nonovert/chronic:</b> Malignancy, vascular malformations, aneurysm"],
                management: ["<b>Treat underlying cause:</b> This is the most important intervention", "<b>Platelet transfusion:</b> If <20K or bleeding", "<b>Cryoprecipitate:</b> If fibrinogen <100-150 mg/dL", "<b>FFP:</b> If PT/PTT >1.5Ã— normal with bleeding", "<b>Heparin:</b> Controversial; consider for thrombotic predominant DIC (cancer)", "<b>ISTH DIC score:</b> â‰¥5 = overt DIC"]
            },
            { id: 61, name: "Heparin-Induced Thrombocytopenia", subtitle: "HIT Workup", category: "coagulation", direction: "low", severity: "critical",
                thresholds: { platelet_drop: ">50% from baseline", timing: "5-10 days after heparin exposure (or sooner if prior exposure)", antibody: "HIT antibody + SRA" },
                differential: ["HIT Type II (immune-mediated)", "Other drug-induced thrombocytopenia", "Sepsis", "DIC", "Post-surgical drop", "Dilutional"],
                management: ["<b>4T's score:</b> Calculate pretest probability (â‰¤3 = low)", "<b>If suspected:</b> STOP all heparin immediately (including flushes, coated lines)", "<b>Non-heparin anticoagulation:</b> Argatroban or bivalirudin (preferred in AKI for argatroban)", "<b>NO platelet transfusion</b> (may worsen thrombosis)", "<b>Labs:</b> HIT antibody (ELISA); if positive â†’ confirmatory SRA", "<b>Warfarin:</b> Do NOT start until platelets >150K (risk of limb gangrene)"]
            },
            { id: 62, name: "Antithrombin III", subtitle: "AT3 Deficiency", category: "coagulation", direction: "low", severity: "moderate",
                thresholds: { normal: "80-120%", low: "<80%", hereditary: "<50%", severe: "<20%" },
                differential: ["Hereditary AT3 deficiency", "Acquired: Liver disease, nephrotic syndrome, DIC, heparin therapy, L-asparaginase", "Acute thrombosis (consumed)"],
                management: ["<b>Heparin resistance:</b> AT3 deficiency can cause inadequate aPTT response to heparin", "<b>AT3 concentrate:</b> Available for hereditary deficiency or heparin resistance", "<b>Thrombosis risk:</b> Increased risk of VTE in hereditary deficiency", "<b>Testing:</b> Avoid during acute thrombosis or on heparin/DOACs"]
            },
            // IRON STUDIES (63-66)
            { id: 63, name: "Elevated Ferritin", subtitle: "Hyperferritinemia", category: "iron", direction: "high", severity: "moderate",
                thresholds: { normal: "M: 30-400 ng/mL, F: 15-150 ng/mL", mild: "400-1000 ng/mL", moderate: "1000-5000 ng/mL", severe: "5000-10000 ng/mL", critical: ">10000 ng/mL" },
                differential: ["Iron overload (hemochromatosis, transfusion-dependent anemia)", "Acute phase reactant (infection, inflammation, malignancy)", "Liver disease", "Hemophagocytic lymphohistiocytosis (HLH)", "Still's disease", "Renal failure"],
                management: ["<b>Check transferrin saturation:</b> >45% suggests iron overload", "<b>Inflammation:</b> Ferritin elevates disproportionately to iron stores", "<b>HFE gene testing:</b> For suspected hereditary hemochromatosis", "<b>Hemochromatosis:</b> Phlebotomy to ferritin <50-100 ng/mL", "<b>Ferritin >10000:</b> Think HLH, Still's disease; check triglycerides, fibrinogen"]
            },
            { id: 64, name: "Low Ferritin", subtitle: "Iron Deficiency", category: "iron", direction: "low", severity: "moderate",
                thresholds: { normal: "M: 30-400 ng/mL, F: 15-150 ng/mL", borderline: "15-30 ng/mL", deficient: "<15 ng/mL", severe: "<10 ng/mL" },
                differential: ["Chronic blood loss (GI most common, menorrhagia)", "Inadequate dietary intake", "Malabsorption (celiac, gastric bypass, H. pylori)", "Pregnancy", "Frequent blood donation"],
                management: ["<b>Ferritin <30:</b> Highly suggestive of iron deficiency", "<b>Workup:</b> Evaluate for GI blood loss (EGD, colonoscopy in appropriate patients)", "<b>Oral iron:</b> Ferrous sulfate 325mg PO daily-TID (take on empty stomach with vitamin C)", "<b>IV iron:</b> If malabsorption, intolerance, or rapid correction needed (iron sucrose, ferric carboxymaltose)", "<b>Response:</b> Reticulocyte count increases in 1 week; Hgb rises 1-2 g/dL over 3-4 weeks"]
            },
            { id: 65, name: "Low Transferrin Saturation", subtitle: "TSAT", category: "iron", direction: "low", severity: "moderate",
                thresholds: { normal: "20-50%", low: "<20%", deficient: "<15%", severe: "<10%" },
                differential: ["Iron deficiency anemia", "Anemia of chronic disease", "Inflammation (TIBC decreases but less than iron)"],
                management: ["<b>Iron deficiency:</b> Low TSAT (<20%) + Low ferritin (<30)", "<b>Anemia of chronic disease:</b> Low TSAT + Normal/high ferritin", "<b>Formula:</b> TSAT = (serum iron / TIBC) Ã— 100", "<b>CKD:</b> Target TSAT 20-50%, ferritin 100-500 for ESA therapy"]
            },
            { id: 66, name: "Elevated TIBC", subtitle: "Total Iron Binding Capacity", category: "iron", direction: "high", severity: "moderate",
                thresholds: { normal: "250-370 Âµg/dL", elevated: ">400 Âµg/dL", high: ">450 Âµg/dL" },
                differential: ["Iron deficiency anemia", "Pregnancy", "Oral contraceptives", "Hepatitis"],
                management: ["<b>High TIBC:</b> Body trying to capture more iron â†’ iron deficiency", "<b>Low TIBC:</b> Inflammation, liver disease, nephrotic syndrome, hemochromatosis", "<b>Combined interpretation:</b> Low iron + high TIBC + low ferritin = iron deficiency"]
            },
            // LIPIDS (67-70)
            { id: 67, name: "Elevated LDL", subtitle: "Low-Density Lipoprotein", category: "lipids", direction: "high", severity: "moderate",
                thresholds: { optimal: "<100 mg/dL", nearnormal: "100-129 mg/dL", borderline: "130-159 mg/dL", high: "160-189 mg/dL", veryhigh: "â‰¥190 mg/dL" },
                differential: ["Primary hyperlipidemia (familial)", "Secondary: Diet, obesity, hypothyroidism, diabetes, nephrotic syndrome, cholestasis", "Medications (thiazides, beta-blockers, steroids)"],
                management: ["<b>ASCVD risk:</b> Use 10-year ASCVD risk calculator for primary prevention", "<b>Very high risk (prior ASCVD):</b> Target LDL <70 (or <55 if very high risk)", "<b>High-intensity statin:</b> Atorvastatin 40-80mg or rosuvastatin 20-40mg", "<b>LDL â‰¥190:</b> Statin indicated regardless of risk score", "<b>Add-on therapy:</b> Ezetimibe, then PCSK9 inhibitor if not at goal"]
            },
            { id: 68, name: "Low HDL", subtitle: "High-Density Lipoprotein", category: "lipids", direction: "low", severity: "moderate",
                thresholds: { optimal: ">60 mg/dL", normal: "40-60 mg/dL", low: "<40 mg/dL (men), <50 mg/dL (women)" },
                differential: ["Metabolic syndrome", "Obesity", "Physical inactivity", "Smoking", "Type 2 diabetes", "Medications (beta-blockers, anabolic steroids)", "Genetic (Tangier disease, LCAT deficiency)"],
                management: ["<b>Lifestyle:</b> Exercise, weight loss, smoking cessation, moderate alcohol", "<b>No HDL-raising drugs proven to reduce CV events</b>", "<b>Focus on:</b> LDL lowering and overall CV risk reduction", "<b>Niacin:</b> Raises HDL but no CV benefit shown in trials"]
            },
            { id: 69, name: "Elevated Triglycerides", subtitle: "Hypertriglyceridemia", category: "lipids", direction: "high", severity: "moderate",
                thresholds: { normal: "<150 mg/dL", borderline: "150-199 mg/dL", high: "200-499 mg/dL", veryhigh: "500-999 mg/dL", severe: "â‰¥1000 mg/dL" },
                differential: ["Obesity/metabolic syndrome", "Diabetes (uncontrolled)", "Alcohol", "Medications (estrogens, steroids, retinoids, beta-blockers, protease inhibitors)", "Hypothyroidism", "Nephrotic syndrome", "Familial hypertriglyceridemia"],
                management: ["<b>TG >500:</b> Pancreatitis risk - fibrates (fenofibrate, gemfibrozil) first-line", "<b>TG 150-500:</b> Address secondary causes; statins if elevated ASCVD risk", "<b>Lifestyle:</b> Weight loss, limit carbs/sugar, reduce alcohol, exercise", "<b>Omega-3 fatty acids:</b> Icosapent ethyl (Vascepa) if TG 150-499 + ASCVD/diabetes on statin", "<b>Severe (>1000):</b> NPO, IV fluids; consider plasmapheresis if pancreatitis"]
            },
            { id: 70, name: "Elevated Lipoprotein(a)", subtitle: "Lp(a)", category: "lipids", direction: "high", severity: "moderate",
                thresholds: { normal: "<30 mg/dL", borderline: "30-50 mg/dL", high: ">50 mg/dL", veryhigh: ">100 mg/dL" },
                differential: ["Genetically determined (not modifiable by lifestyle)", "Associated with increased ASCVD and aortic stenosis risk"],
                management: ["<b>Test once:</b> Genetically determined, doesn't change over time", "<b>Elevated Lp(a):</b> Intensify LDL-lowering (statin + ezetimibe Â± PCSK9i)", "<b>PCSK9 inhibitors:</b> May lower Lp(a) by ~25-30%", "<b>Niacin:</b> Lowers Lp(a) but no proven CV benefit", "<b>Emerging:</b> Antisense oligonucleotides targeting Lp(a) in development"]
            },
            // INFLAMMATORY (71-73)
            { id: 71, name: "Elevated ESR", subtitle: "Erythrocyte Sedimentation Rate", category: "inflammatory", direction: "high", severity: "moderate",
                thresholds: { normal: "M: <15 mm/hr, F: <20 mm/hr (age-adjusted: age/2 for M, (age+10)/2 for F)", mild: "20-50 mm/hr", moderate: "50-100 mm/hr", severe: ">100 mm/hr" },
                differential: ["<b>ESR >100:</b> Infection, malignancy, autoimmune (GCA, PMR, RA, SLE), multiple myeloma, endocarditis, osteomyelitis", "Pregnancy", "Anemia", "End-stage renal disease"],
                management: ["<b>Non-specific:</b> Elevated in many inflammatory states", "<b>GCA suspected:</b> ESR >50 (often >100) + clinical symptoms â†’ temporal artery biopsy, start steroids", "<b>PMR:</b> ESR typically elevated; responds dramatically to low-dose prednisone", "<b>Multiple myeloma:</b> Very high ESR with rouleaux formation", "<b>False elevations:</b> Anemia, pregnancy, older age, obesity"]
            },
            { id: 72, name: "Elevated CRP", subtitle: "C-Reactive Protein", category: "inflammatory", direction: "high", severity: "moderate",
                thresholds: { normal: "<3 mg/L", mild: "3-10 mg/L", moderate: "10-100 mg/L", severe: ">100 mg/L", critical: ">200 mg/L" },
                differential: ["Bacterial infection", "Autoimmune disease flare", "Malignancy", "Trauma/surgery", "MI", "Inflammatory bowel disease"],
                management: ["<b>More rapidly responsive than ESR:</b> Rises within 6-8 hours of inflammation", "<b>CRP >100:</b> Suggests bacterial infection (vs viral)", "<b>hs-CRP:</b> For cardiovascular risk stratification (<1, 1-3, >3 mg/L)", "<b>Trending:</b> Useful for monitoring treatment response", "<b>Unaffected by:</b> Anemia, polycythemia (unlike ESR)"]
            },
            { id: 73, name: "Elevated Uric Acid", subtitle: "Hyperuricemia", category: "inflammatory", direction: "high", severity: "moderate",
                thresholds: { normal: "M: 3.5-7.2 mg/dL, F: 2.5-6.0 mg/dL", elevated: "7-9 mg/dL", high: "9-12 mg/dL", severe: ">12 mg/dL" },
                differential: ["Gout", "Chronic kidney disease", "Tumor lysis syndrome", "Myeloproliferative disorders", "High purine diet", "Alcohol", "Thiazide/loop diuretics", "Metabolic syndrome"],
                management: ["<b>Acute gout:</b> NSAIDs, colchicine, or steroids (NOT urate-lowering therapy acutely)", "<b>Urate-lowering:</b> Allopurinol (start 100mg, titrate to goal) or febuxostat after flare resolves", "<b>Target:</b> Uric acid <6 mg/dL (some advocate <5 for tophaceous gout)", "<b>TLS prevention:</b> IV fluids, allopurinol; rasburicase if high risk", "<b>Asymptomatic hyperuricemia:</b> Generally not treated"]
            },
            // ABG/ACID-BASE (74-77)
            { id: 74, name: "ABG - Respiratory Acidosis", subtitle: "Elevated PaCO2", category: "abg", direction: "high", severity: "severe",
                thresholds: { normal: "PaCO2 35-45 mmHg", mild: "45-55 mmHg", moderate: "55-70 mmHg", severe: "70-90 mmHg", critical: ">90 mmHg" },
                differential: ["<b>Acute:</b> Opioids/sedatives, neuromuscular disease (MG, GBS), severe asthma/COPD exacerbation, airway obstruction", "<b>Chronic:</b> COPD, obesity hypoventilation, neuromuscular disease, kyphoscoliosis"],
                management: ["<b>Acute:</b> Expected HCO3 rise = 1 mEq for each 10 mmHg rise in PaCO2", "<b>Chronic:</b> Expected HCO3 rise = 3.5 mEq for each 10 mmHg rise in PaCO2", "<b>Treat underlying cause:</b> Reverse opioids (naloxone), bronchodilators, BiPAP", "<b>BiPAP:</b> First-line for COPD exacerbation with respiratory acidosis", "<b>Intubation:</b> If failing BiPAP, fatigue, or airway compromise"]
            },
            { id: 75, name: "ABG - Respiratory Alkalosis", subtitle: "Low PaCO2", category: "abg", direction: "low", severity: "moderate",
                thresholds: { normal: "PaCO2 35-45 mmHg", mild: "30-35 mmHg", moderate: "25-30 mmHg", severe: "20-25 mmHg", critical: "<20 mmHg" },
                differential: ["Anxiety/pain/hyperventilation", "Hypoxia (PE, pneumonia, high altitude)", "Sepsis/fever", "Pregnancy", "Liver failure", "CNS disease", "Salicylate toxicity (early)"],
                management: ["<b>Acute:</b> Expected HCO3 drop = 2 mEq for each 10 mmHg drop in PaCO2", "<b>Chronic:</b> Expected HCO3 drop = 5 mEq for each 10 mmHg drop in PaCO2", "<b>Anxiety/hyperventilation:</b> Reassurance; paper bag rebreathing is outdated", "<b>Rule out hypoxia:</b> Check A-a gradient", "<b>Sepsis:</b> Often presents with respiratory alkalosis before obvious signs"]
            },
            { id: 76, name: "ABG - Hypoxemia", subtitle: "Low PaO2", category: "abg", direction: "low", severity: "critical",
                thresholds: { normal: "PaO2 80-100 mmHg (on RA)", mild: "60-79 mmHg", moderate: "50-59 mmHg", severe: "40-49 mmHg", critical: "<40 mmHg" },
                differential: ["<b>Normal A-a gradient:</b> Hypoventilation, low FiO2 (altitude)", "<b>Elevated A-a gradient:</b> V/Q mismatch (PE, COPD, pneumonia), shunt (ARDS, ASD, pulmonary AVM), diffusion impairment (ILD)"],
                management: ["<b>A-a gradient:</b> = PAO2 - PaO2 = (150 - PaCO2/0.8) - PaO2; normal = (age/4) + 4", "<b>Supplemental O2:</b> Target SpO2 88-92% in COPD, 92-96% otherwise", "<b>High-flow nasal cannula:</b> Up to 60L/min FiO2 100%", "<b>BiPAP:</b> If hypercapnic or impending fatigue", "<b>Intubation:</b> If refractory hypoxemia, airway compromise, altered mental status"]
            },
            { id: 77, name: "Elevated A-a Gradient", subtitle: "Alveolar-arterial Gradient", category: "abg", direction: "high", severity: "moderate",
                thresholds: { normal: "5-15 mmHg (or age/4 + 4)", mildlyelevated: "15-30 mmHg", moderatelyelevated: "30-50 mmHg", severlyelevated: ">50 mmHg" },
                differential: ["<b>V/Q mismatch:</b> COPD, asthma, PE, pneumonia, atelectasis", "<b>Shunt:</b> ARDS, pneumonia, pulmonary edema, ASD/VSD, pulmonary AVM", "<b>Diffusion impairment:</b> ILD, pulmonary fibrosis"],
                management: ["<b>Calculate:</b> A-a = (150 - PaCO2/0.8) - PaO2 (at sea level, room air)", "<b>Normal A-a + hypoxemia:</b> Hypoventilation or low FiO2 - will correct with O2", "<b>Elevated A-a + hypoxemia:</b> Parenchymal lung disease or PE - needs workup", "<b>Shunt:</b> Does NOT correct with 100% O2 (blood bypassing alveoli)"]
            },
            // BODY FLUIDS (78-82)
            { id: 78, name: "Pleural Fluid Analysis", subtitle: "Thoracentesis", category: "bodyfluid", direction: "high", severity: "moderate",
                thresholds: { transudative: "Protein <3, LDH <200, <60% serum LDH, <50% serum protein", exudative: "Meets Light's criteria" },
                differential: ["<b>Transudative:</b> CHF (most common), cirrhosis, nephrotic syndrome, PE", "<b>Exudative:</b> Infection (parapneumonic, empyema, TB), malignancy, PE, autoimmune, pancreatitis"],
                management: ["<b>Light's criteria (any 1 = exudate):</b> Pleural protein/serum protein >0.5; Pleural LDH/serum LDH >0.6; Pleural LDH >2/3 upper normal serum", "<b>Empyema:</b> Pleural pH <7.2, glucose <60, LDH >1000, pus, positive culture â†’ chest tube", "<b>Parapneumonic:</b> Antibiotics; drain if complicated (pH <7.2)", "<b>Malignant:</b> Cytology, pleurodesis for recurrent symptomatic effusions"]
            },
            { id: 79, name: "CSF Analysis", subtitle: "Lumbar Puncture", category: "bodyfluid", direction: "high", severity: "critical",
                thresholds: { normal: "WBC 0-5, glucose 50-80, protein 15-45 mg/dL", bacterial: "WBC >1000 (PMN), low glucose, high protein", viral: "WBC 10-500 (lymphocytes), normal glucose, mildly elevated protein" },
                differential: ["<b>Bacterial meningitis:</b> WBC >1000, glucose <40, protein >200, PMN predominant", "<b>Viral meningitis:</b> WBC 10-500, normal glucose, protein <100, lymphocyte predominant", "<b>TB/fungal:</b> WBC 50-500, low glucose, high protein, lymphocyte predominant", "<b>SAH:</b> Xanthochromia, RBCs (don't clear with serial tubes)"],
                management: ["<b>Bacterial meningitis:</b> Empiric ceftriaxone + vancomycin + dexamethasone (before or with first antibiotic dose)", "<b>HSV encephalitis:</b> IV acyclovir; temporal lobe involvement", "<b>Opening pressure:</b> >25 cm H2O elevated; consider IIH, infection, mass", "<b>Gram stain + culture:</b> Essential; PCR panel increasingly available"]
            },
            { id: 80, name: "Synovial Fluid Analysis", subtitle: "Arthrocentesis", category: "bodyfluid", direction: "high", severity: "severe",
                thresholds: { normal: "WBC <200, clear, viscous", noninflammatory: "WBC 200-2000", inflammatory: "WBC 2000-50000", septic: "WBC >50000 (often >100000)" },
                differential: ["<b>Non-inflammatory:</b> Osteoarthritis, trauma", "<b>Inflammatory:</b> Gout, pseudogout, RA, reactive arthritis", "<b>Septic:</b> Bacterial infection - orthopedic emergency"],
                management: ["<b>Septic arthritis:</b> Immediate I&D/washout + IV antibiotics (vanc + ceftriaxone empirically)", "<b>Crystal analysis:</b> Gout = negatively birefringent urate; pseudogout = positively birefringent CPPD", "<b>Gram stain:</b> Positive in only ~50% of septic arthritis", "<b>Culture:</b> Essential; gonococcal often requires special media", "<b>Do NOT delay:</b> Joint infection causes rapid cartilage destruction"]
            },
            { id: 81, name: "Peritoneal Fluid - SBP", subtitle: "Spontaneous Bacterial Peritonitis", category: "bodyfluid", direction: "high", severity: "critical",
                thresholds: { normal: "PMN <250/mmÂ³", SBP: "PMN â‰¥250/mmÂ³", secondary: "Multiple organisms, protein >1g/dL, LDH elevated" },
                differential: ["Spontaneous bacterial peritonitis (cirrhosis)", "Secondary peritonitis (perforation - surgical emergency)", "Culture-negative neutrocytic ascites", "Tuberculous peritonitis"],
                management: ["<b>SBP diagnosis:</b> PMN â‰¥250 (culture often negative)", "<b>Treatment:</b> Ceftriaxone 2g IV daily Ã— 5 days (or cefotaxime)", "<b>Albumin:</b> 1.5 g/kg day 1, 1 g/kg day 3 if Cr >1, BUN >30, or bili >4", "<b>Prophylaxis:</b> Prior SBP, GI bleed, or ascites protein <1.5 â†’ norfloxacin or TMP-SMX", "<b>Rule out secondary:</b> Multiple organisms, very high protein, surgical abdomen"]
            },
            { id: 82, name: "Urine Analysis", subtitle: "UA Interpretation", category: "urine", direction: "high", severity: "moderate",
                thresholds: { WBC: ">5/hpf = pyuria", RBC: ">3/hpf = hematuria", bacteria: "Any = significant in symptomatic", protein: ">trace = abnormal" },
                differential: ["<b>Pyuria:</b> UTI, sterile pyuria (STI, TB, interstitial nephritis)", "<b>Hematuria:</b> UTI, stones, malignancy, glomerulonephritis", "<b>Proteinuria:</b> Glomerular disease, overflow (myeloma), tubular", "<b>Casts:</b> RBC = GN; WBC = pyelonephritis/AIN; muddy brown = ATN; hyaline = normal"],
                management: ["<b>UTI:</b> Dysuria + pyuria + bacteriuria; treat symptomatic only", "<b>Asymptomatic bacteriuria:</b> Treat only in pregnancy or pre-urologic procedure", "<b>Sterile pyuria:</b> Consider STI (urethritis), TB, AIN, recent ABx", "<b>Dysmorphic RBCs or RBC casts:</b> Glomerulonephritis - nephrology referral"]
            },
            // INFECTIOUS (83-87)
            { id: 83, name: "HIV Testing", subtitle: "HIV Antibody/Antigen", category: "infectious", direction: "high", severity: "critical",
                thresholds: { negative: "Non-reactive 4th gen Ag/Ab", acute: "Positive Ag (p24), negative/indeterminate Ab", chronic: "Positive Ab + confirmatory" },
                differential: ["Acute HIV infection (flu-like illness 2-4 weeks post-exposure)", "Chronic HIV infection", "AIDS (CD4 <200 or AIDS-defining illness)"],
                management: ["<b>4th generation test:</b> Detects p24 antigen + HIV-1/2 antibodies", "<b>Window period:</b> ~2-4 weeks for 4th gen tests", "<b>Confirmatory:</b> HIV-1/HIV-2 differentiation assay; HIV RNA if early infection", "<b>Newly diagnosed:</b> CD4 count, viral load, genotype, screen for OIs, start ART", "<b>ART:</b> Start immediately regardless of CD4 count"]
            },
            { id: 84, name: "Hepatitis Panel", subtitle: "Viral Hepatitis Serologies", category: "infectious", direction: "high", severity: "severe",
                thresholds: { HBsAg: "Positive = active HBV", antiHBs: "Positive = immunity", antiHBcIgM: "Positive = acute HBV", HCVAb: "Positive = exposure (need RNA)" },
                differential: ["Hepatitis A: HAV IgM (acute), HAV IgG (past/immune)", "Hepatitis B: Various serologic patterns", "Hepatitis C: Anti-HCV Ab, confirm with HCV RNA"],
                management: ["<b>Acute HBV:</b> HBsAg+, anti-HBc IgM+; supportive care; 95% adults clear spontaneously", "<b>Chronic HBV:</b> HBsAg+ >6 months; check HBV DNA, consider antiviral therapy", "<b>HCV:</b> Anti-HCV positive â†’ check HCV RNA; if positive â†’ treat with DAAs (cure >95%)", "<b>Immune (vaccination):</b> Anti-HBs+ only", "<b>Immune (prior infection):</b> Anti-HBs+ and anti-HBc+"]
            },
            { id: 85, name: "Blood Cultures", subtitle: "Bacteremia/Fungemia", category: "infectious", direction: "high", severity: "critical",
                thresholds: { negative: "No growth 5 days", positive: "Growth with identification/sensitivities", contaminant: "Coag-neg staph (single bottle), diphtheroids" },
                differential: ["<b>True bacteremia:</b> S. aureus, gram-negatives, S. pneumoniae, enterococci", "<b>Likely contaminants:</b> Coag-neg staph (1 of 2 sets), diphtheroids, Bacillus", "<b>Fungemia:</b> Candida - always significant"],
                management: ["<b>S. aureus bacteremia:</b> ALWAYS significant - ID consult, TTE (TEE if any risk factors), 4-6 weeks IV ABx for complicated", "<b>Gram-negative:</b> Source control, targeted antibiotics", "<b>Candidemia:</b> Echinocandin first-line; remove lines; ophthalmology consult; 14 days after first negative culture", "<b>Contaminant suspected:</b> Repeat cultures before treating"]
            },
            { id: 86, name: "Rapid Strep/Monospot", subtitle: "Pharyngitis Testing", category: "infectious", direction: "high", severity: "moderate",
                thresholds: { RADT: "Positive or negative", monospot: "Positive or negative" },
                differential: ["Group A strep pharyngitis", "Infectious mononucleosis (EBV)", "Viral pharyngitis (most common)", "Gonococcal pharyngitis", "Other bacteria (Arcanobacterium, Fusobacterium)"],
                management: ["<b>GAS pharyngitis:</b> Penicillin V 500mg BID Ã— 10 days or amoxicillin 1g daily Ã— 10 days", "<b>Penicillin allergy:</b> Cephalexin or azithromycin (increasing resistance)", "<b>Mononucleosis:</b> Supportive care; avoid contact sports (splenomegaly); no amoxicillin (rash)", "<b>Centor criteria:</b> Fever, tonsillar exudates, tender anterior cervical LAD, absence of cough"]
            },
            { id: 87, name: "C. difficile Testing", subtitle: "CDI Diagnosis", category: "infectious", direction: "high", severity: "severe",
                thresholds: { PCR: "Positive or negative", toxin: "Positive or negative", twoStep: "GDH screen then toxin" },
                differential: ["Clostridioides difficile infection", "Other antibiotic-associated diarrhea", "Viral gastroenteritis", "IBD flare"],
                management: ["<b>Non-severe:</b> Vancomycin 125mg PO QID Ã— 10 days OR fidaxomicin 200mg BID Ã— 10 days", "<b>Severe (WBC >15K, Cr >1.5):</b> Same oral therapy; consider PO vancomycin 500mg QID if fulminant", "<b>Fulminant:</b> Vanc 500mg PO QID + metronidazole 500mg IV q8h; consider rectal vanc; surgical consult", "<b>Recurrent:</b> Fidaxomicin; bezlotoxumab; consider FMT after 2nd recurrence", "<b>Stop unnecessary antibiotics:</b> Critical for treatment success"]
            },
            // TUMOR MARKERS (88-92)
            { id: 88, name: "PSA", subtitle: "Prostate-Specific Antigen", category: "tumor", direction: "high", severity: "moderate",
                thresholds: { normal: "<4.0 ng/mL", gray: "4-10 ng/mL", elevated: ">10 ng/mL", veryhigh: ">20 ng/mL" },
                differential: ["Prostate cancer", "BPH", "Prostatitis", "Recent ejaculation", "Urinary retention", "Prostatic manipulation", "Age-related increase"],
                management: ["<b>Screening:</b> Shared decision-making in men 55-69; not recommended >70", "<b>Free PSA:</b> Low % free PSA (<10%) more concerning for cancer", "<b>PSA velocity:</b> >0.75 ng/mL/year increase concerning", "<b>Elevated PSA:</b> Urology referral for possible biopsy (MRI fusion increasingly used)", "<b>Post-prostatectomy:</b> PSA should be undetectable; any rise = recurrence"]
            },
            { id: 89, name: "CA-125", subtitle: "Ovarian Cancer Marker", category: "tumor", direction: "high", severity: "moderate",
                thresholds: { normal: "<35 U/mL", mild: "35-65 U/mL", moderate: "65-200 U/mL", high: ">200 U/mL", veryhigh: ">500 U/mL" },
                differential: ["Epithelial ovarian cancer", "Endometriosis", "Pregnancy", "Menstruation", "PID", "Cirrhosis", "Peritonitis", "Other malignancies (pancreas, breast, lung)"],
                management: ["<b>Not for screening:</b> Low specificity in premenopausal women", "<b>Postmenopausal with pelvic mass:</b> Elevated CA-125 concerning for malignancy", "<b>Monitoring:</b> Useful for treatment response and recurrence detection", "<b>Other uses:</b> Trending in ovarian cancer treatment"]
            },
            { id: 90, name: "CEA", subtitle: "Carcinoembryonic Antigen", category: "tumor", direction: "high", severity: "moderate",
                thresholds: { normal: "<3.0 ng/mL (non-smokers), <5.0 ng/mL (smokers)", mild: "5-10 ng/mL", moderate: "10-20 ng/mL", high: ">20 ng/mL" },
                differential: ["Colorectal cancer", "Other GI cancers (pancreas, gastric)", "Lung cancer", "Breast cancer", "Smoking", "Cirrhosis", "IBD", "Pancreatitis"],
                management: ["<b>Not for screening:</b> Low sensitivity and specificity", "<b>Colorectal cancer:</b> Baseline before treatment; monitor for recurrence", "<b>Surveillance:</b> Check q3 months Ã— 2 years, then q6 months Ã— 3-5 years", "<b>Rising CEA post-resection:</b> Workup for recurrence (CT, PET)"]
            },
            { id: 91, name: "AFP", subtitle: "Alpha-Fetoprotein", category: "tumor", direction: "high", severity: "moderate",
                thresholds: { normal: "<10 ng/mL", mild: "10-100 ng/mL", moderate: "100-400 ng/mL", high: ">400 ng/mL", diagnostic: ">400 with mass = HCC in cirrhosis" },
                differential: ["Hepatocellular carcinoma", "Germ cell tumors (testicular, ovarian)", "Pregnancy", "Cirrhosis (mild elevation)", "Acute/chronic hepatitis", "Ataxia-telangiectasia"],
                management: ["<b>HCC surveillance in cirrhosis:</b> AFP + ultrasound q6 months", "<b>AFP >400 + liver mass in cirrhosis:</b> Diagnostic for HCC (no biopsy needed)", "<b>Germ cell tumors:</b> AFP + beta-hCG for diagnosis and monitoring", "<b>False positives:</b> Pregnancy, hepatitis, regenerating liver"]
            },
            { id: 92, name: "CA 19-9", subtitle: "Pancreatic Cancer Marker", category: "tumor", direction: "high", severity: "moderate",
                thresholds: { normal: "<37 U/mL", mild: "37-100 U/mL", moderate: "100-500 U/mL", high: ">500 U/mL", veryhigh: ">1000 U/mL" },
                differential: ["Pancreatic cancer", "Cholangiocarcinoma", "Biliary obstruction (benign)", "Other GI cancers", "Pancreatitis", "Cirrhosis"],
                management: ["<b>Not for screening</b>", "<b>Pancreatic cancer:</b> May be elevated; higher levels = worse prognosis", "<b>Biliary obstruction:</b> Can cause false elevation; recheck after decompression", "<b>Lewis antigen negative:</b> ~5% population won't produce CA 19-9", "<b>Monitoring:</b> Treatment response and recurrence in pancreatic cancer"]
            },
            // DRUG LEVELS (93-97)
            { id: 93, name: "Digoxin Level", subtitle: "Digitalis Toxicity", category: "drugs", direction: "high", severity: "critical",
                thresholds: { therapeutic: "0.5-1.0 ng/mL (HFrEF), <2.0 ng/mL (afib)", elevated: "2.0-3.0 ng/mL", toxic: ">3.0 ng/mL" },
                differential: ["Intentional overdose", "Drug interactions (amiodarone, verapamil, quinidine)", "Renal impairment (decreased clearance)", "Hypokalemia/hypomagnesemia (increased toxicity)"],
                management: ["<b>Classic toxicity:</b> GI (nausea, vomiting), visual (yellow-green halos), cardiac (bradycardia, AV block, afib with slow response, bidirectional VT)", "<b>Hold digoxin, correct K and Mg</b>", "<b>DigiFab indications:</b> Life-threatening arrhythmias, K >5.5, ingestion >10mg, level >10 ng/mL", "<b>DigiFab dosing:</b> Based on ingested amount or serum level", "<b>Avoid cardioversion:</b> May precipitate VF in dig toxicity"]
            },
            { id: 94, name: "Vancomycin AUC/Trough", subtitle: "Vancomycin Monitoring", category: "drugs", direction: "high", severity: "severe",
                thresholds: { trough_goal: "10-20 mcg/mL (traditional)", AUC_goal: "400-600 mcgÂ·h/mL (preferred)", nephrotoxic: "Trough >20 or AUC >600" },
                differential: ["Renal impairment (decreased clearance)", "Obesity (Vd changes)", "Critical illness (variable PK)", "Drug interactions"],
                management: ["<b>AUC-based monitoring preferred:</b> AUC/MIC 400-600 for S. aureus", "<b>Trough monitoring:</b> Draw immediately before 4th dose (at steady state)", "<b>Loading dose:</b> 25-30 mg/kg Ã— 1 for serious infections", "<b>Nephrotoxicity:</b> Risk increases with trough >20, concomitant nephrotoxins, prolonged therapy", "<b>Target infections:</b> MRSA bacteremia, endocarditis, osteomyelitis, pneumonia"]
            },
            { id: 95, name: "Aminoglycoside Levels", subtitle: "Gentamicin/Tobramycin", category: "drugs", direction: "high", severity: "severe",
                thresholds: { peak_gent: "5-10 mcg/mL (traditional)", trough_gent: "<2 mcg/mL (traditional)", extended_interval: "Undetectable trough" },
                differential: ["Renal impairment", "Critical illness", "Obesity", "Cystic fibrosis (increased clearance)"],
                management: ["<b>Extended-interval dosing:</b> 5-7 mg/kg q24h (most common) - use Hartford nomogram", "<b>Traditional dosing:</b> For endocarditis, synergy - peak 3-5 mcg/mL, trough <1 mcg/mL", "<b>Nephrotoxicity:</b> Risk increases with elevated troughs, duration >5-7 days, concurrent nephrotoxins", "<b>Ototoxicity:</b> May be irreversible; monitor for vestibular and auditory symptoms", "<b>Duration:</b> Limit to shortest effective course"]
            },
            { id: 96, name: "Phenytoin Level", subtitle: "Antiepileptic Monitoring", category: "drugs", direction: "high", severity: "severe",
                thresholds: { therapeutic: "10-20 mcg/mL (total)", free_therapeutic: "1-2 mcg/mL", toxic: ">20 mcg/mL", severe: ">30 mcg/mL" },
                differential: ["Drug interactions (highly protein-bound, CYP inducer)", "Hypoalbuminemia (increases free fraction)", "Renal failure (decreases protein binding)", "Non-linear kinetics (small dose changes â†’ large level changes)"],
                management: ["<b>Correct for albumin:</b> Corrected = measured / (0.2 Ã— albumin + 0.1)", "<b>Corrected in renal failure:</b> Corrected = measured / (0.1 Ã— albumin + 0.1)", "<b>Free level:</b> More accurate in hypoalbuminemia, renal failure, pregnancy", "<b>Toxicity:</b> Nystagmus (15-25), ataxia (25-40), lethargy/coma (>40)", "<b>Loading:</b> 15-20 mg/kg IV; max rate 50 mg/min (cardiac monitoring)"]
            },
            { id: 97, name: "Lithium Level", subtitle: "Mood Stabilizer Monitoring", category: "drugs", direction: "high", severity: "critical",
                thresholds: { therapeutic: "0.6-1.2 mEq/L", high_therapeutic: "1.0-1.2 mEq/L (acute mania)", toxic: "1.5-2.5 mEq/L", severe: "2.5-3.5 mEq/L", lifethreatening: ">3.5 mEq/L" },
                differential: ["Dehydration/volume depletion", "Renal impairment", "Drug interactions (NSAIDs, ACEi/ARB, thiazides)", "Infection/fever", "Low-salt diet"],
                management: ["<b>Draw level:</b> 12 hours after last dose (trough)", "<b>Early toxicity:</b> GI (nausea, diarrhea), fine tremor, polyuria", "<b>Severe toxicity:</b> Coarse tremor, ataxia, confusion, seizures, arrhythmias", "<b>Management:</b> IV fluids, hold lithium; consider hemodialysis if >4 mEq/L, severe symptoms, or renal failure", "<b>Chronic toxicity:</b> Can occur at lower levels; may be more dangerous than acute"]
            },
            // MISCELLANEOUS (98-100)
            { id: 98, name: "Osmolality (Serum)", subtitle: "Serum Osmolarity", category: "misc", direction: "high", severity: "moderate",
                thresholds: { normal: "275-295 mOsm/kg", low: "<275 mOsm/kg", high: ">295 mOsm/kg", critical: ">320 mOsm/kg" },
                differential: ["<b>Elevated:</b> Hyperglycemia, hypernatremia, uremia, ethanol, toxic alcohols, mannitol", "<b>Low:</b> Hyponatremia, overhydration"],
                management: ["<b>Calculated osmolality:</b> 2(Na) + glucose/18 + BUN/2.8", "<b>Osmolar gap:</b> Measured - calculated (normal <10)", "<b>Elevated osmolar gap:</b> Toxic alcohols (methanol, ethylene glycol, isopropanol), propylene glycol", "<b>HHS:</b> Often osmolality >320; aggressive hydration", "<b>SIADH:</b> Low serum osmolality (<275) with inappropriately concentrated urine"]
            },
            { id: 99, name: "Lactate Dehydrogenase", subtitle: "LDH", category: "misc", direction: "high", severity: "moderate",
                thresholds: { normal: "140-280 U/L", mild: "280-500 U/L", moderate: "500-1000 U/L", high: ">1000 U/L", veryhigh: ">2000 U/L" },
                differential: ["Hemolysis", "Tissue infarction (MI, stroke, mesenteric ischemia)", "Malignancy (especially lymphoma, germ cell tumors)", "Liver disease", "Muscle damage", "PCP pneumonia", "Pulmonary embolism"],
                management: ["<b>Non-specific marker of cell turnover/damage</b>", "<b>Hemolysis workup:</b> LDH elevated + low haptoglobin + reticulocytosis", "<b>TTP:</b> Markedly elevated LDH (hemolysis)", "<b>PCP:</b> LDH elevation correlates with disease severity in HIV", "<b>Lymphoma:</b> Elevated LDH is poor prognostic marker"]
            },
            { id: 100, name: "Haptoglobin", subtitle: "Hemolysis Marker", category: "misc", direction: "low", severity: "moderate",
                thresholds: { normal: "30-200 mg/dL", low: "<30 mg/dL", undetectable: "<10 mg/dL" },
                differential: ["<b>Low/undetectable:</b> Intravascular hemolysis (AIHA, TTP, HUS, DIC, mechanical valves, PNH, transfusion reaction)", "Extravascular hemolysis (less prominent decrease)", "Liver disease (decreased synthesis)", "Genetic ahaptoglobinemia"],
                management: ["<b>Hemolysis workup:</b> Low haptoglobin + elevated LDH + elevated indirect bilirubin + reticulocytosis", "<b>Direct Coombs:</b> Positive = immune-mediated (warm AIHA, cold agglutinin, drug-induced)", "<b>Smear:</b> Schistocytes (TTP, HUS, DIC), spherocytes (AIHA, hereditary spherocytosis)", "<b>Acute phase reactant:</b> May be falsely normal in hemolysis + inflammation"]
            }
        ];

        // State
        let activeFilters = { category: 'all', direction: 'all', search: '' };

        // Category display names
        const categoryNames = {
            electrolytes: 'Electrolytes', cbc: 'Complete Blood Count', renal: 'Renal Function',
            hepatic: 'Hepatic Function', cardiac: 'Cardiac Markers', endocrine: 'Endocrine',
            coagulation: 'Coagulation', inflammatory: 'Inflammatory Markers', iron: 'Iron Studies',
            lipids: 'Lipid Panel', urine: 'Urinalysis', abg: 'ABG/Acid-Base',
            bodyfluid: 'Body Fluid Analysis', infectious: 'Infectious Disease', tumor: 'Tumor Markers',
            drugs: 'Drug Levels', misc: 'Miscellaneous'
        };

        // Render functions
        function renderLabCard(lab) {
            const thresholdHtml = Object.entries(lab.thresholds).map(([key, value]) => `
                <div class="threshold-item">
                    <div class="threshold-label">${key}</div>
                    <div class="threshold-value">${value}</div>
                </div>
            `).join('');

            const differentialHtml = lab.differential.map(d => `<div class="list-item">${d}</div>`).join('');
            const managementHtml = lab.management.map(m => `<div class="list-item">${m}</div>`).join('');

            return `
                <div class="lab-card" id="lab-${lab.id}">
                    <div class="lab-header">
                        <div>
                            <div class="lab-title">${lab.id}. ${lab.name}</div>
                            <div class="lab-subtitle">${lab.subtitle}</div>
                        </div>
                        <div class="badge-container">
                            <span class="badge badge-${lab.direction}">${lab.direction === 'high' ? 'â†‘ HIGH' : 'â†“ LOW'}</span>
                            <span class="badge badge-${lab.severity}">${lab.severity.toUpperCase()}</span>
                        </div>
                    </div>
                    <div class="section">
                        <div class="section-title">ðŸ“Š Reference Thresholds</div>
                        <div class="threshold-grid">${thresholdHtml}</div>
                    </div>
                    <div class="section">
                        <div class="section-title">ðŸ” Differential Diagnosis</div>
                        ${differentialHtml}
                    </div>
                    <div class="section">
                        <div class="section-title">ðŸ’Š Management</div>
                        ${managementHtml}
                    </div>
                </div>
            `;
        }

        function renderLabCards() {
            const filtered = labValues.filter(lab => {
                const matchesCategory = activeFilters.category === 'all' || lab.category === activeFilters.category;
                const matchesDirection = activeFilters.direction === 'all' || lab.direction === activeFilters.direction;
                const searchLower = activeFilters.search.toLowerCase();
                const matchesSearch = !searchLower || 
                    lab.name.toLowerCase().includes(searchLower) ||
                    lab.subtitle.toLowerCase().includes(searchLower) ||
                    lab.differential.some(d => d.toLowerCase().includes(searchLower)) ||
                    lab.management.some(m => m.toLowerCase().includes(searchLower));
                return matchesCategory && matchesDirection && matchesSearch;
            });

            document.getElementById('labGrid').innerHTML = filtered.map(renderLabCard).join('');
            document.getElementById('resultsInfo').textContent = `Showing ${filtered.length} of ${labValues.length} laboratory values`;
        }

        function generateTOC() {
            const categories = {};
            labValues.forEach(lab => {
                if (!categories[lab.category]) categories[lab.category] = [];
                categories[lab.category].push(lab);
            });

            document.getElementById('tocGrid').innerHTML = Object.keys(categories).map(category => `
                <div class="toc-category">
                    <h4>${categoryNames[category] || category}</h4>
                    <ul class="toc-list">
                        ${categories[category].map(lab => `
                            <li><a href="#lab-${lab.id}" class="toc-link">${lab.id}. ${lab.name}</a></li>
                        `).join('')}
                    </ul>
                </div>
            `).join('');
        }

        // Event listeners
        document.getElementById('tocToggle').addEventListener('click', () => {
            document.getElementById('tocContent').classList.toggle('show');
        });

        document.getElementById('categoryFilters').addEventListener('click', (e) => {
            if (e.target.classList.contains('filter-btn')) {
                document.querySelectorAll('#categoryFilters .filter-btn').forEach(btn => btn.classList.remove('active'));
                e.target.classList.add('active');
                activeFilters.category = e.target.dataset.category;
                renderLabCards();
            }
        });

        document.getElementById('directionFilters').addEventListener('click', (e) => {
            if (e.target.classList.contains('filter-btn')) {
                document.querySelectorAll('#directionFilters .filter-btn').forEach(btn => btn.classList.remove('active'));
                e.target.classList.add('active');
                activeFilters.direction = e.target.dataset.direction;
                renderLabCards();
            }
        });

        document.getElementById('searchBox').addEventListener('input', (e) => {
            activeFilters.search = e.target.value;
            renderLabCards();
        });

        // Back to top
        const backToTopBtn = document.getElementById('backToTop');
        window.addEventListener('scroll', () => {
            backToTopBtn.classList.toggle('show', window.scrollY > 500);
        });
        backToTopBtn.addEventListener('click', () => window.scrollTo({ top: 0, behavior: 'smooth' }));

        // Initialize
        renderLabCards();
        generateTOC();
    </script>
</body>
</html>
